Myocardial infarction, strict

I9_MI_STRICT

coronary thrombosis: Coagulation of blood in any of the coronary vessels. The presence of a blood clot (thrombus) often leads to myocardial infarction.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Main diagnosis only: side diagnoses are not checked. Registry filters: Hospital discharge: ICD-10 — I21, I22 Hospital discharge: ICD-9 — 410 Hospital discharge: ICD-8 — 410 Hospital discharge: excluded ICD-10 — I21.90, I21.97, I22.90, I22.97 Cause of death: ICD-10 — I21, I22 Cause of death: ICD-9 — 410 Cause of death: ICD-8 — 410 Cause of death: excluded ICD-10 — I21.90, I21.97, I22.90, I22.97 2 out of 7 registries used, show all original rules.	32644
4. Check minimum number of events None	32644
5. Include endpoints None	32644
6. Filter based on genotype QC (FinnGen only)	32644

Control definitions (FinnGen only)

Control exclude: I9_ISCHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4

NAME	I9_MI_STRICT
CONTROL_EXCLUDE	I9_ISCHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY	YES
HD_ICD_10_ATC
HD_ICD_10	I21\|I22
HD_ICD_9	410
HD_ICD_8	410
HD_ICD_10_EXCL	I2190\|I2197\|I2290\|I2297
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY	YES
COD_ICD_10	I21\|I22
COD_ICD_9	410
COD_ICD_8	410
COD_ICD_10_EXCL	I2190\|I2197\|I2290\|I2297
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Myocardial infarction, strict based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	463154	166806	284587
Only index persons	216802	83212	133590
Unadjusted period prevalence (%)
Whole population	6.92	4.78	7.95
Only index persons	4.32	3.06	5.10
Median age at first event (years)
Whole population	69.65	75.90	66.10
Only index persons	69.63	76.53	65.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	32644	8946	23698
Unadjusted period prevalence (%)	8.42	3.05	10.45
Median age at first event (years)	67.25	71.07	65.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12297: Matched controls
108415

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AN1

Coronary angiography

36.9

323.0

4728

1805

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

323.0

335

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

181.6

323.0

2889

183

I25.2

ICD-10 Finland

Old myocardial infarction

2913.2

323.0

4075

R07.4

ICD-10 Finland

Chest pain, unspecified

4.3

323.0

5159

15566

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

1421

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

1306

280

Kela drug reimbursment

Clopidogrel

1064.2

323.0

576

AN4

Balloon angioplasty and drug eluding stent

+∞

323.0

1874

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

6088.9

323.0

1262

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

27.2

323.0

7733

6355

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

323.0

1163

I50.9

ICD-10 Finland

Heart failure, unspecified

6.0

323.0

2224

3862

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

548.2

323.0

8825

500

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

323.0

6729

33556

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

323.0

604

C03CA01

ATC

furosemide; systemic

3.7

323.0

4467

14330

I50.1

ICD-10 Finland

Left ventricular failure

10.5

323.0

970

879

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.3

323.0

993

1494

C09AA05

ATC

ramipril; oral

6.2

323.0

6053

14641

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

936

I25

ICD-10 Finland

Chronic ischaemic heart disease

90.5

323.0

1708

193

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

11.7

323.0

1043

849

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5231.1

323.0

1586

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

544

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

2988

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

+∞

323.0

627

K76

ICPC

Ischaemic heart dis without angina

68.5

323.0

806

111

C10AA07

ATC

rosuvastatin; oral

2.9

323.0

4366

17445

I20.01

ICD-10 Finland

Unstable angina

2561.6

323.0

1100

C10AA01

ATC

simvastatin; oral

3.4

323.0

7457

33890

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.5

323.0

3524

14844

I20.00

ICD-10 Finland

Unstable angina

995.5

323.0

940

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

135.6

323.0

2180

172

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

70.7

323.0

470

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

323.0

8429

50820

Angiography of the heart and coronary arteries

28.4

323.0

1536

541

C10AA05

ATC

atorvastatin; oral

6.4

323.0

8539

28251

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

498.1

323.0

490

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3557.3

323.0

3843

Single vessel balloon catheter extension

+∞

323.0

712

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

562.2

323.0

432

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.0

323.0

4699

11976

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

89.0

323.0

605

C10AX09

ATC

ezetimibe; oral

9.2

323.0

3644

4751

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

1190.6

323.0

518

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

839.8

323.0

1864

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

25.9

323.0

1663

651

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4541.5

323.0

970

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

5859.9

323.0

4456

WX872

NOMESCO Finland

Intensive care

7.6

323.0

1393

1789

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

323.0

439

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

1507

I20.99

ICD-10 Finland

Angina pectoris, unspecified

130.4

323.0

1485

114

I20.90

ICD-10 Finland

Angina pectoris, unspecified

271.3

323.0

721

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1767.4

323.0

1371

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

9.5

323.0

4162

5523

I25.1

ICD-10 Finland

Atherosclerotic heart disease

683.3

323.0

8650

378

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

323.0

4232

C03DA01

ATC

spironolactone; oral

3.6

323.0

1760

4747

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

685

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.8

323.0

4149

8719

C07AB02

ATC

metoprolol; systemic

3.1

323.0

3101

10567

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

2442

XF400

NOMESCO Finland

ECG with 12 standard connections

3.9

323.0

3202

9052

I50.0

ICD-10 Finland

Congestive heart failure

7.5

323.0

1158

1479

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

323.0

341

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.4

323.0

2055

4756

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.9

323.0

3564

13231

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

172.2

323.0

1687

100

AN3

Balloon angioplasty and metallic stent

+∞

323.0

1390

AA1

Conventional CABG

+∞

323.0

500

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

111.8

323.0

728

103

Kela drug reimbursment

Diabetes, insulin-treated

2.6

323.0

4227

18314

XF402

NOMESCO Finland

ECG with work load test

4.1

323.0

2187

5444

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

11.6

323.0

734

589

C01DA14

ATC

isosorbide mononitrate; oral

33.5

323.0

3978

1527

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

70.3

323.0

9401

4777

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

1501.3

323.0

629

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.5

323.0

4018

7509

AN2

Balloon angioplasty, including several vessels

+∞

323.0

1063

C07AB07

ATC

bisoprolol; oral

8.0

323.0

9493

32326

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

654.3

323.0

361

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.4

323.0

3915

17911

B01AC04

ATC

clopidogrel; oral

21.5

323.0

5856

4389

I20.09

ICD-10 Finland

Unstable angina

362.6

323.0

2040

Coronary artery bypass surgery

+∞

323.0

376

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

8053.7

323.0

2275

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

6.0

323.0

1614

2681

B01AC24

ATC

ticagrelor; oral

5852.9

323.0

3461

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.6

319.5

1643

4442

A10BA02

ATC

metformin; oral

2.3

315.2

4090

19532

A02BC02

ATC

pantoprazole; systemic

2.1

311.1

8466

55443

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

311.0

312

201

Kela drug reimbursment

Chronic cardiac insufficiency

7.5

309.2

789

981

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.5

306.2

1219

2612

A10AE04

ATC

insulin glargine; parenteral

3.5

304.6

1646

4619

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.3

301.0

1243

2759

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

297.1

2259

8037

Z50.0

ICD-10 Finland

Cardiac rehabilitation

65.1

294.7

358

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

107.1

289.7

331

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

1357.8

289.4

295

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

2527.4

285.5

289

WX892

NOMESCO Finland

Monitored bed care

3.8

285.3

1370

3479

C08CA01

ATC

amlodipine; oral

2.1

284.1

5110

27835

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

1320.3

282.4

288

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

280.8

1759

5486

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

2426.2

274.6

278

B01AA03

ATC

warfarin; systemic

2.6

271.8

2475

9734

K74

ICPC

Ischaemic heart dis with angina

37.3

263.9

354

I20.91

ICD-10 Finland

Angina pectoris, unspecified

611.6

262.8

272

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.2

257.0

1515

4502

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

249.4

2416

9774

205

Kela drug reimbursment

Chronic hypertension

2.1

245.3

3753

18814

T90

ICPC

Diabetes non-insulin dependent

2.1

244.8

3462

16779

AP1

Catheterization of the left side of the heart

19.1

244.6

394

187

R06.0

ICD-10 Finland

Dyspnoea

2.2

243.4

3128

14519

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

243.0

1227

3228

R4110

NOMESCO Finland

Physiotherapy

2.1

242.9

3780

19068

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

237.5

2928

13310

K84

ICPC

Heart disease other

8.3

237.1

563

621

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.3

236.9

2735

12050

FL1AC

NOMESCO Finland

Left cardioangiography

19.7

235.9

376

173

A11

ICPC

Chest pain NOS

3.5

235.4

1253

3435

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

315.1

233.2

247

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

357.5

227.8

240

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

15.2

224.0

393

235

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

266.8

220.9

236

B01AC22

ATC

prasugrel; oral

407.7

217.4

228

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.7

215.9

1058

2704

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

20.5

215.0

338

149

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

96.6

213.9

247

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

7.4

209.8

536

662

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.0

202.3

883

2037

C10AA04

ATC

fluvastatin; oral

2.9

194.0

1319

4277

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

193.7

1029

2798

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

4.7

193.6

724

1436

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

193.3

3769

20359

R07.3

ICD-10 Finland

Other chest pain

2.9

193.0

1341

4411

C10AA03

ATC

pravastatin; oral

3.2

189.6

1118

3286

A10AA02

ATC

6.0

189.5

565

863

Catheterization and pressure measurement of the left side of the heart

25.1

188.9

279

100

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

1632.6

187.8

191

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.8

184.6

674

1302

A10AE05

ATC

insulin detemir; parenteral

3.7

184.4

879

2186

207

Kela drug reimbursment

Chronic arrhythmias

2.3

181.8

1895

7821

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

5.5

181.8

585

981

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

831.2

180.9

186

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

826.7

179.9

185

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

175.0

176

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

1669.5

174.8

178

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

239.8

174.1

187

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

4.4

172.8

682

1425

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

171.4

2602

12670

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

163.1

164

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

1528.3

161.9

165

SPAT1262

SPAT

Handing over of treatment supplies

2.0

159.2

2497

12265

A10AA01

ATC

5.8

156.4

475

741

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

155.6

1886

8303

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

8.0

155.5

377

428

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

155.1

156

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

155.1

156

ANB

Coronary thrombectomy

+∞

153.1

154

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

+∞

150.1

151

XF404

NOMESCO Finland

Ambulatory ECG

2.6

150.1

1278

4709

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

19.2

148.9

239

112

I20

ICD-10 Finland

Angina pectoris

13.4

147.9

272

182

I20.0

ICD-10 Finland

Unstable angina

34.1

145.1

198

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

140.1

1104

3883

A10BK03

ATC

empagliflozin; oral

2.6

140.0

1149

4139

I47.2

ICD-10 Finland

Ventricular tachycardia

6.8

139.8

378

505

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

28.0

139.7

200

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.8

137.6

630

1505

Multi-vessel balloon catheter extension

+∞

137.2

138

A10BB12

ATC

glimepiride; oral

2.9

135.2

902

2861

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.6

135.2

1124

4073

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

+∞

135.2

136

I20.10

ICD-10 Finland

Angina angiospastic

1222.4

133.1

136

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

5.4

132.3

428

720

AA1AD

NOMESCO Finland

CT of head and brain

1.8

132.2

2905

15934

N02AX02

ATC

tramadol; systemic, rectal

1.6

131.8

5210

33859

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

4.5

130.1

499

1010

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.1

129.7

1610

7114

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.3

129.6

706

1940

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.8

128.0

463

882

I21

ICD-10 Finland

Acute myocardial infarction

202.0

125.4

136

I20.9

ICD-10 Finland

Angina pectoris, unspecified

20.9

123.4

192

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

1121.2

123.2

126

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

+∞

122.2

123

111

Conventional CABG

+∞

122.2

123

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

6.8

120.8

326

434

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

117.3

1058

3998

SPAT1097

SPAT

Recording of ECG

1.9

114.5

1884

9285

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

217.2

113.1

122

C09AA02

ATC

enalapril; systemic

1.8

112.7

2402

12943

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

20.0

112.2

177

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

13.8

111.4

202

131

M04AA01

ATC

allopurinol; systemic

2.0

109.8

1541

7134

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

108.7

2067

10704

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.0

108.4

702

2173

H3603, E103

ICD-10 Finland

9.7

107.6

231

213

N02BE01

ATC

paracetamol; systemic, rectal

1.7

106.9

10262

81048

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

+∞

106.3

107

ANE

Coronary internal ultrasound (IVUS)

968.4

106.3

109

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

106.0

3330

20054

C01BD01

ATC

amiodarone; systemic

4.2

104.8

435

949

FXZ00

NOMESCO Finland

Off-pump cardiac operation

34.2

104.4

142

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

103.8

1084

4397

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

941.5

103.3

106

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

102.1

1113

4606

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.6

101.7

382

756

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

923.5

101.3

104

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

+∞

101.3

102

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

101.2

698

2251

TK800

NOMESCO Finland

Hemodialysis

4.5

101.2

383

764

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

99.4

526

1410

AA2

Off pump CABG sternotomy

+∞

99.3

100

K01

ICPC

Heart pain

8.2

98.8

234

256

K75

ICPC

Acute myocardial infarction

70.1

98.6

118

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

11.7

97.9

191

146

5315

FHL

Bypass surgery using a mammary artery

+∞

97.3

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.6

97.3

472

1180

I50

ICD-10 Finland

Heart failure

4.6

97.2

359

698

C08DB01

ATC

diltiazem; oral

3.1

97.0

569

1645

T89

ICPC

Diabetes insulin dependent

3.3

96.5

523

1427

A10BH01

ATC

sitagliptin; oral

2.1

96.5

1248

5565

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

96.4

A10BB01

ATC

glibenclamide; oral

4.2

95.8

389

831

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

6.9

95.1

251

324

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.7

95.1

447

1089

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

93.3

3227

19794

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.3

93.0

204

196

I20.8

ICD-10 Finland

Other forms of angina pectoris

47.7

92.9

118

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.6

92.5

346

682

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

+∞

92.4

C09DX04

ATC

valsartan and sacubitril; oral

12.2

91.2

174

127

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

85.7

90.9

106

FN2EA

NOMESCO Finland

Coronary rotablation

+∞

90.4

C01AA05

ATC

digoxin; systemic

2.7

90.1

674

2282

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

88.7

777

2874

B01AF02

ATC

apixaban; oral

2.1

88.0

1172

5280

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

87.3

1321

6257

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

9.5

87.1

189

178

R07.2

ICD-10 Finland

Precordial pain

4.8

86.9

310

581

N18.8

ICD-10 Finland

Other chronic renal failure

4.0

86.6

373

842

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

+∞

86.4

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

86.4

1246

5793

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.2

86.2

284

488

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.6

86.0

319

623

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

10.9

85.7

173

142

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.2

85.6

493

1406

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

12.1

85.6

164

121

B01AC07

ATC

dipyridamole; systemic

3.9

85.4

378

874

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

85.1

1214

5618

C08CA07

ATC

nisoldipine; oral

14.9

83.9

147

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

12.3

82.5

157

114

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.3

82.3

324

672

R53

ICD-10 Finland

Malaise and fatigue

1.7

81.4

1932

10634

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.7

81.1

248

390

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

+∞

80.4

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

5.1

80.2

268

468

PE1AT

NOMESCO Finland

Femoral artery PTA

7.3

80.2

203

247

NHQ40

NOMESCO Finland

Amputation of toe

5.2

79.8

264

456

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.8

79.6

557

1807

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

6.5

79.3

220

305

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.9

78.8

515

1601

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.3

78.7

223

318

A10BH05

ATC

linagliptin; oral

2.7

78.7

583

1960

WX890

NOMESCO Finland

Intesive care monitoring

11.9

78.3

151

113

J01FF01

ATC

clindamycin; systemic

1.5

77.1

3080

19384

R02

ICPC

Shortness of breath/dyspnoea

1.9

77.0

1278

6247

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

76.8

3105

19594

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

6.2

75.9

216

310

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.6

75.9

283

556

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

75.9

1017

4578

SPAT1254

SPAT

Administration of medicine

1.8

75.8

1481

7657

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

+∞

75.5

ZX120

NOMESCO Finland

Intravenous

2.0

74.9

1083

5027

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

74.8

802

3275

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.1

74.7

439

1269

C08CA02

ATC

felodipine; oral

2.0

74.6

1080

5013

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

74.5

732

2868

C08CA13

ATC

lercanidipine; oral

1.7

74.2

1611

8605

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

13.9

74.0

133

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.6

73.4

226

359

B04AB02

ATC

6.3

73.1

206

292

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

73.1

1262

6249

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

6.6

72.9

199

270

H02AB06

ATC

prednisolone; systemic

1.4

72.8

5077

35772

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

9.1

72.7

161

158

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

6.3

72.5

205

292

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

72.3

675

2576

R03BB04

ATC

tiotropium bromide; inhalant

2.0

71.7

1044

4856

H3603, E113

ICD-10 Finland

7.4

71.6

180

217

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.3

71.6

284

594

A12BA01

ATC

potassium chloride; oral

3.0

71.2

449

1363

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

69.9

1516

8083

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

42.0

69.4

M10.9

ICD-10 Finland

Gout, unspecified

2.2

69.3

773

3212

I20.19

ICD-10 Finland

Angina angiospastic

321.6

69.1

I21.30

ICD-10 Finland

Acute transmural myocardial infarction with unspecified location no detected stenosis of coronary artery

628.2

68.7

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.2

68.5

276

586

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.3

68.0

376

1041

A11CC03

ATC

alfacalcidol; systemic

3.7

67.6

313

753

H3601, E113

ICD-10 Finland

4.8

67.4

238

442

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.5

66.9

337

869

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.6

65.8

202

320

FXG00

NOMESCO Finland

Insertion and use of IABP

41.9

65.5

N02AA05

ATC

oxycodone; systemic

1.7

65.5

1571

8622

R2110

NOMESCO Finland

Giving the first information

2.3

65.4

664

2641

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

64.9

604

2298

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

+∞

64.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

63.8

1152

5778

A28

ICPC

Limited function/disability NOS

1.7

63.8

1465

7933

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

63.7

1747

9948

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.8

63.4

223

413

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

4.6

63.3

231

445

C02AC05

ATC

moxonidine; oral

2.4

63.1

587

2234

C10AA02

ATC

lovastatin; oral

2.8

62.8

430

1375

C07AG02

ATC

carvedilol; oral

2.2

62.6

675

2761

SPAT1263

SPAT

Sampling

1.4

61.9

4397

30783

TFN40

NOMESCO Finland

Catheterisation of heart with balloon widening of coronary vessels

+∞

61.6

C02EA02

ATC

2.7

61.5

451

1505

K22

ICPC

Risk factor cardiovascular disease

2.2

61.4

648

2622

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

5.7

61.2

186

291

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

60.9

1426

7756

K77

ICPC

Heart failure

4.8

60.8

214

397

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4.5

60.7

230

460

WX720

NOMESCO Finland

Own respiration

2.7

60.7

446

1490

S97

ICPC

Chronic ulcer skin

2.3

60.7

634

2553

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

+∞

60.6

C10AX13

ATC

evolocumab; parenteral

64.8

60.6

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

60.4

287

706

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.9

60.2

208

378

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

59.8

707

3013

C09AA04

ATC

perindopril; oral

2.3

59.6

622

2504

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

+∞

59.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

59.3

1453

8004

A12AA04

ATC

calcium carbonate; oral

4.5

59.3

222

439

TFN04

NOMESCO Finland

38.4

59.1

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

8.5

58.9

135

141

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

539.0

58.8

5314

FHL

Bypass surgery for four or more vessels

+∞

58.6

R55

ICD-10 Finland

Syncope and collapse

1.8

57.9

1064

5361

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

57.7

5164

37476

41099

ICD-8 Finland

Acute myocardial infarction, Without mention of hypertensive disease

+∞

57.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

57.5

549

2115

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.7

56.7

425

1436

N03AX16

ATC

pregabalin; oral

1.5

56.5

2610

16755

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

56.2

4147

29087

1CX08

NOMESCO Finland

13.1

56.0

103

I44.2

ICD-10 Finland

Atrioventricular block, complete

3.9

56.0

243

553

SPAT1104

SPAT

Monitoring of emergency patient

2.0

55.6

741

3318

A10AE06

ATC

insulin degludec; parenteral

2.9

55.5

365

1136

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

5.2

55.4

182

313

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

55.4

328

953

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

55.3

848

4010

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

6.9

55.1

144

185

K02

ICPC

Pressure/tightness of heart

3.3

55.0

291

780

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

54.9

2952

19520

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

54.7

647

2757

PD5AD

NOMESCO Finland

CT of aorta

4.4

54.6

211

431

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.6

54.5

423

1459

A10BK01

ATC

dapagliflozin; oral

2.2

54.2

591

2426

5253

FHL

Cardiac lung machine

22.0

54.1

A46

ICD-10 Finland

Erysipelas

1.6

53.7

1552

8926

I42.8

ICD-10 Finland

Other cardiomyopathies

9.8

53.6

113

102

C09CA01

ATC

losartan; oral

1.4

53.3

2806

18457

XPX08

NOMESCO Finland

Intraoperative flow measurement

7.8

53.2

128

145

N19

ICD-10 Finland

Unspecified kidney failure

3.0

53.0

331

998

R04.0

ICD-10 Finland

Epistaxis

2.0

52.9

751

3446

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.6

52.5

193

375

PD3AT

NOMESCO Finland

Pelvic artery PTA

10.0

52.1

109

A02BC01

ATC

omeprazole; systemic

1.4

52.1

2823

18664

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

+∞

51.6

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

51.5

740

3411

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.6

51.3

389

1325

H36.01

ICD-10 Finland

Diabetic maculopathy

4.8

51.2

180

334

J01MA12

ATC

levofloxacin; systemic

1.5

51.2

1963

12075

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

51.0

3331

22773

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

50.9

148

220

K29

ICPC

Cardiovascular sympt/complt other

2.4

50.8

472

1794

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.6

50.3

123

143

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.1

50.3

301

883

R42

ICD-10 Finland

Dizziness and giddiness

1.5

50.2

2160

13616

PEN23

NOMESCO Finland

Plastic repair of femoral artery

6.6

50.2

135

181

H3600, E103

ICD-10 Finland

5.3

50.1

162

274

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.8

50.0

351

1141

I21.3

ICD-10 Finland

Acute transmural myocardial infarction of unspecified site

458.8

49.9

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

+∞

49.6

287

Kela drug reimbursment

Ticagrelor 60 mg

+∞

49.6

N18.0

ICD-10 Finland

End-stage renal disease

5.1

49.6

166

292

K92

ICPC

Atherosclerosis/periph vascular dis

5.3

49.6

160

270

H04AA01

ATC

glucagon; nasal, parenteral

3.7

49.6

231

560

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.9

49.4

312

948

C08CA05

ATC

nifedipine; systemic

2.1

49.3

600

2584

K78

ICPC

Atrial fibrillation/flutter

1.9

49.2

744

3493

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.5

49.2

152

244

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

49.0

4060

28847

315

Kela drug reimbursment

Clopidogrel

6.3

48.9

137

194

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

48.7

758

3596

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.0

48.7

115

127

C03AA03

ATC

hydrochlorothiazide; oral

1.7

48.3

1033

5451

CKC15

NOMESCO Finland

Panretinal photocoagulation

6.6

48.2

130

175

WX722

NOMESCO Finland

PEEP

2.1

48.0

598

2600

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.1

47.7

198

434

GD1LA

NOMESCO Finland

4.3

47.6

186

385

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.5

47.1

230

580

H3601, E103

ICD-10 Finland

5.5

47.0

146

236

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

9.8

46.9

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.0

46.8

158

281

SPAT1301

SPAT

No procedures

1.4

46.7

3211

22080

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

46.0

630

2849

J01DB01

ATC

cefalexin; oral

1.4

45.9

9251

74842

C07AB03

ATC

atenolol; systemic

2.1

45.9

576

2515

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

45.9

696

3273

A10BJ06

ATC

semaglutide; parenteral

2.4

45.8

417

1569

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.8

45.6

C09CA03

ATC

valsartan; oral

1.7

45.5

1025

5487

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

45.4

486

1976

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.6

45.1

121

162

L28

ICPC

Limited function/disability (L)

1.5

44.9

1527

9111

H3600, E113

ICD-10 Finland

4.3

44.9

176

366

I21.42

ICD-10 Finland

Acute subendocardial infarction thrombus in coronary artery

+∞

44.7

4109X

ICD-9 Finland

Acute myocardial infarction, Unspecified site[INFARCTUS MYOCARDII ACUTUS SUSPECTUS,MÄÄRITTELEMÄT]

+∞

44.7

FNA96

NOMESCO Finland

Other connection to coronary artery from internal mammary artery

+∞

44.7

R03AC02

ATC

salbutamol; inhalant

1.3

44.3

5201

38787

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

44.2

482

1977

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.8

44.1

298

945

I21.08

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

43.7

R11

ICD-10 Finland

Nausea and vomiting

1.9

43.4

699

3358

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

43.3

1215

6908

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.5

43.2

347

1222

I49.5

ICD-10 Finland

Sick sinus syndrome

2.5

42.5

341

1199

I51.4

ICD-10 Finland

Myocarditis, unspecified

7.9

42.3

101

114

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

42.2

359

1305

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

42.1

2349

15512

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

13.8

42.1

A02BA02

ATC

ranitidine; systemic

1.4

42.0

2001

12822

C02DE04

ATC

3.6

41.9

199

491

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

41.7

604

2788

B01AB05

ATC

enoxaparin; parenteral

1.3

41.6

3336

23429

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

41.4

461

1910

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.3

41.4

222

603

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

7.5

41.4

102

121

WX882

NOMESCO Finland

High dependency care

2.6

41.2

314

1073

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

41.1

1548

9437

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.7

41.0

289

942

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

7.8

41.0

111

M79.6

ICD-10 Finland

Pain in limb

1.3

40.9

3638

25953

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.7

40.8

291

955

N07BA03

ATC

varenicline; oral

2.0

40.8

561

2540

WX730

NOMESCO Finland

Conventional respirator

3.5

40.6

204

527

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

4.4

40.1

153

310

M01AH05

ATC

etoricoxib; oral

0.8

40.1

5316

53735

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

39.9

216

591

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.9

39.8

173

396

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

39.8

765

3898

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

9.7

39.7

V03AE01

ATC

polystyrene sulfonate; oral

4.4

39.6

152

310

A06AD11

ATC

lactulose; oral

1.6

39.4

1246

7291

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

39.3

592

2773

C10AB02

ATC

bezafibrate; oral

4.2

39.2

156

330

I20.08

ICD-10 Finland

Unstable angina

360.7

39.1

C09AA01

ATC

captopril; oral

3.8

39.0

174

408

SPAT1310

SPAT

Counselling related to known health issue

1.3

38.9

3264

23033

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

5.3

38.8

124

208

N05CF01

ATC

zopiclone; oral

1.3

38.8

3280

23178

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

59.3

38.7

I22.99

ICD-10 Finland

Recurrent infarction with unspecified location unspecified coronary artery status

+∞

38.7

J01DA01

ATC

[U] cefalexin; systemic

1.3

38.7

6562

51057

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.2

38.7

156

334

137

Kela drug reimbursment

Uraemia requiring dialysis

5.1

38.7

127

220

SPAT1252

SPAT

Overall medication plan or its review

1.8

38.6

679

3356

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.1

38.6

128

224

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

38.3

209

576

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

6.1

38.2

109

159

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.5

37.9

110

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

37.8

749

3852

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

37.8

1528

9449

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

5.4

37.8

118

193

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

37.8

1313

7854

TFN50

NOMESCO Finland

Catheterisation of heart with application of stent

+∞

37.7

WW502

NOMESCO Finland

Autotransfusion

7.6

37.6

108

AS7

Arrhythmia pacemaker insertion VVI (R) S

16.6

37.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.1

37.5

154

336

CKC12

NOMESCO Finland

Photocoagulation of retina

2.0

37.4

500

2237

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

6.2

37.3

105

151

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

37.3

2695

18557

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

6.9

37.1

123

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.7

37.0

111

173

K92.1

ICD-10 Finland

Melaena

2.0

36.9

482

2136

E87.5

ICD-10 Finland

Hyperkalaemia

3.6

36.8

174

429

A04

ICPC

Weakness/tiredness general

1.6

36.8

1055

6020

4110X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Postmyocardial infarction syndrome[EPÄSTABIILI ANGINA PECTORIS,MÄÄRITTELEMÄT]

+∞

36.7

I21.98

ICD-10 Finland

Myocardial infarction (acute) UNS other occlusion in the coronary artery

+∞

36.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

36.7

1155

6746

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

17.1

36.7

XF640

NOMESCO Finland

2.5

36.6

304

1090

B04AB01

ATC

5.6

36.5

111

176

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

36.4

297

1057

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

7.1

36.1

115

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

36.0

1662

10556

Z49.2

ICD-10 Finland

Other dialysis

5.8

35.7

106

163

I21.18

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

35.7

A10AA03

ATC

6.6

35.4

128

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

35.1

1134

6661

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

35.1

197

555

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

34.7

666

3387

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

4.6

34.7

125

240

WX900

NOMESCO Finland

Resuscitation

9.4

34.5

L04AA06

ATC

mycophenolic acid; systemic

2.9

34.5

216

655

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

34.4

524

2462

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

6.1

34.4

140

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

6.1

34.2

141

K99

ICPC

Cardiovascular disease other

2.6

34.2

270

943

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

34.2

399

1689

SPAT1255

SPAT

Intravenous administration of medicine

1.8

34.1

656

3341

N03AX12

ATC

gabapentin; oral

1.5

34.1

1551

9810

R50.9

ICD-10 Finland

Fever, unspecified

1.5

34.1

1251

7563

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

34.1

905

5059

A02BC03

ATC

lansoprazole; oral

1.3

34.0

2972

21021

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

60.3

33.9

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

33.6

550

2653

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

14.7

33.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

33.4

2084

13964

G47.3

ICD-10 Finland

Sleep apnoea

1.4

33.4

2428

16687

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

33.3

1602

10239

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

33.3

204

610

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3.2

33.3

181

498

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.1

33.2

191

548

160

Kela drug reimbursment

exenatide

2.5

33.0

262

918

K28

ICPC

Limited function/disability (K)

2.8

32.8

215

673

I24.1

ICD-10 Finland

Dressler syndrome

+∞

32.7

EBA00

NOMESCO Finland

Extraction of tooth

1.3

32.7

3270

23552

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

32.7

1392

8684

NGQ20

NOMESCO Finland

Amputation of lower leg

7.9

32.6

C09BA02

ATC

enalapril and diuretics; systemic

1.6

32.4

886

4991

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019060) Gas panel - Arterial blood

2703

8891

2.38

321.89

5.7

4.5

—

(3023368) Bacteria identified in Blood by Culture

8305

40978

1.75

314.60

5.1

4.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4530

16056

2.32

307.65

8.9

6.9

11.5

12.4

kpa

23.11

4290

15335

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4923

19688

2.05

307.65

3.3

2.3

g/l

0.75

4599

18049

(3020779) Urea [Moles/volume] in Serum or Plasma

3589

12612

2.27

307.65

10.3

6.4

11.7

10.1

mmol/l

24.57

3392

11935

(3013826) Glucose [Moles/volume] in Serum or Plasma

14777

83027

1.83

307.65

7.2

4.5

7.3

6.8

mmol/l

124.86

14188

77923

(3016502) Oxygen saturation in Arterial blood

4156

14295

2.37

307.65

9.2

7.3

95.3

95.6

2.42

3997

13799

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5712

20993

2.31

307.65

2.6

1.9

31.6

29.6

63.13

5555

20358

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3756

13128

2.30

307.65

9.8

7.7

120.0

121.7

g/l

4.90

3632

12668

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4531

16065

2.32

307.65

8.9

6.9

5.0

5.1

kpa

13.45

4291

15352

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8788

42935

1.80

307.65

2.5

2.1

224.9

222.5

u/l

0.10

8230

40127

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4651

10576

3.77

307.65

3.0

2.0

11.9

6.0

ug/l

23.69

4145

8875

(3022948) Iron [Moles/volume] in Serum or Plasma

5169

21220

2.00

307.65

3.3

2.4

11.2

13.0

umol/l

62.61

4839

19473

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10646

40752

2.69

307.65

4.2

2.6

2502.4

1209.5

ng/l

69.47

9717

34460

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7693

25899

2.75

307.65

7.1

3.0

1761.1

187.8

ng/l

56.82

7196

21028

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11687

52645

2.26

307.65

6.5

3.1

239.9

34.5

ng/l

6.48

9639

39025

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4743

18468

2.10

307.65

3.4

2.4

19.8

23.2

55.91

4084

15625

(3032080) INR in Blood by Coagulation assay

12394

59441

2.13

307.65

12.2

8.5

1.3

inr

10.34

3254

15940

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3808

11325

2.74

307.65

4.0

2.5

323.9

175.1

ng/l

41.79

3550

10248

(3003396) Base excess in Arterial blood by calculation

4522

16080

2.31

307.65

8.9

6.9

0.8

1.0

mmol/l

2.16

3510

12795

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1761

4815

2.81

303.76

3.5

2.7

0.3

0.4

u/ml

1.24

1101

2590

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2528

8295

2.37

301.61

8.4

6.7

24.3

24.7

mmol/l

5.89

2374

7714

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7049

33850

1.75

287.58

2.6

2.2

3.2

3.0

mg/l

7.44

6090

28369

(3012544) pH of Venous blood

3516

13659

2.04

275.27

5.1

3.5

7.4

0.85

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5245

23542

1.81

265.36

2.0

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4293

18398

1.86

249.98

9.1

6.8

104.4

104.3

mmol/l

0.56

4156

18027

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3349

13266

1.99

246.07

5.0

3.5

5.8

kpa

0.13

3240

12920

(3002032) Base excess in Venous blood by calculation

3340

13259

1.98

243.72

5.1

3.5

1.7

1.9

mmol/l

2.07

2719

10872

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2474

8910

2.15

233.59

11.4

8.7

0.7

0.03

2454

8856

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3783

15903

1.88

232.01

1.9

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2219

7702

2.22

229.28

12.4

9.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4480

19997

1.79

225.92

28.8

25.0

1.5

1.4

inr

5.49

591

2799

(3000991) Gas panel - Venous blood

3065

12136

1.97

223.79

11.1

7.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2455

8964

2.12

223.26

11.1

8.7

1.4

1.22

2436

8907

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3766

16007

1.86

222.24

1.9

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4994

23122

1.74

221.41

3.7

3.4

0.8

mmol/l

1.41

4653

21448

(3020682) Albumin/Creatinine [Ratio] in Urine

8791

47153

1.58

218.47

4.3

3.9

16.2

8.0

mg/mmol

24.45

5877

29648

(3014007) Fractional oxyhemoglobin in Arterial blood

2445

8998

2.10

217.56

11.5

8.8

93.7

93.9

1.04

2434

8970

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5591

26942

1.68

212.88

2.3

1.6

1.4

1.5

mg/l

0.20

4456

20970

(3012516) Albumin [Mass/volume] in Urine

8371

44660

1.58

210.73

3.5

3.2

334.4

423.3

mg/l

1.20

5782

28073

(3014111) Lactate [Moles/volume] in Serum or Plasma

3157

12895

1.91

209.41

9.3

6.5

1.4

mmol/l

3.47

3014

12438

(3004451) EKG impression Narrative

413

509

6.01

204.29

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

2718

10834

1.94

192.65

4.1

2.8

4.6

kpa

0.81

2615

10497

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4117

18730

1.74

190.54

8.2

5.4

1.1

1.0

mmol/l

37.51

3847

17297

(3009508) Creatinine [Moles/volume] in Urine

8383

45670

1.53

185.68

3.4

3.2

7.2

7.7

mmol/l

27.88

6942

37711

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

12387

73289

1.50

185.31

6.5

6.7

12.3

12.1

umol/l

1.13

11819

69475

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2087

7946

2.01

167.25

11.6

8.7

24.0

24.4

mmol/l

3.71

1908

7429

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8852

49818

1.48

160.99

3.6

2.7

160.9

174.8

ug/l

3.22

8153

45011

(3000963) Hemoglobin [Mass/volume] in Blood

19127

149690

0.60

159.46

36.9

22.1

132.0

136.2

g/l

218.24

18855

147019

(3026361) Erythrocytes [#/volume] in Blood

19125

149661

0.60

158.82

36.6

22.0

4.4

4.5

e12/l

151.45

18555

144347

(3024731) MCV [Entitic volume]

19125

149655

0.60

158.59

36.5

21.9

91.8

91.5

15.13

18848

146962

(3010813) Leukocytes [#/volume] in Blood

19129

149677

0.60

158.53

36.6

22.0

7.5

6.8

e9/l

185.31

18567

144392

(3035941) MCH [Entitic mass]

19124

149632

0.60

157.96

36.4

21.9

30.4

30.5

5.25

18847

146946

(3027945) Reticulocytes/100 erythrocytes in Blood

3671

16966

1.69

157.16

2.3

2.5

1.9

1.7

11.35

3261

14823

(3018405) Lactate [Moles/volume] in Arterial blood

1387

4608

2.27

156.93

4.8

4.0

1.5

1.4

mmol/l

2.69

1357

4534

(3007461) Platelets [#/volume] in Blood

19124

149583

0.60

156.15

36.6

22.0

236.1

243.2

e9/l

38.60

18638

144845

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1607

5685

2.14

156.05

6.1

4.7

1.8

1.6

2.84

1509

5360

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1499

5159

2.20

155.86

3.0

2.1

591.1

578.7

ug/l

0.05

1447

4846

(3007930) Methemoglobin/Hemoglobin.total in Blood

1571

5587

2.13

150.35

6.2

4.8

0.9

1.16

1477

5268

(3004119) Hemoglobin [Mass/volume] in Venous blood

2137

8580

1.90

145.92

4.5

2.9

123.5

130.0

g/l

29.59

2066

8401

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2114

8537

1.89

141.63

9.8

6.5

24.4

24.9

mmol/l

6.63

2095

8455

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1778

6770

1.99

141.47

5.4

3.8

23.8

24.2

mmol/l

5.09

1582

6103

(3043409) Potassium [Moles/volume] in Arterial blood

1198

3940

2.29

138.40

5.2

4.2

4.0

3.9

mmol/l

6.08

1102

3702

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1738

6786

1.94

128.23

1.6

1.7

1.6

g/l

4.89

1519

5756

(3047181) Lactate [Moles/volume] in Blood

1188

4098

2.18

122.13

7.5

5.7

1.4

1.3

mmol/l

2.44

1061

3620

(3018572) Chloride [Moles/volume] in Blood

929

2918

2.38

118.81

8.0

6.5

105.0

104.8

mmol/l

0.33

844

2640

(3039000) Anion gap in Blood

929

2918

2.38

118.81

8.0

6.5

11.6

11.1

mmol/l

3.13

844

2640

(3020891) Body temperature

1428

5382

2.00

116.19

5.9

4.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1919

8081

1.80

111.32

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1544

6074

1.92

110.88

2.1

2.0

2.3

ug/l

0.39

1375

5290

(3027273) Bicarbonate [Moles/volume] in Venous blood

1703

6919

1.86

110.84

4.4

3.1

25.0

25.2

mmol/l

1.97

1650

6735

(3023520) Reticulocytes [#/volume] in Blood

2755

12848

1.64

110.52

2.4

2.7

71.9

67.8

e9/l

6.62

2098

9727

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1634

6665

1.85

104.83

3.5

2.6

1.3

1.2

0.46

1625

6638

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7298

42044

1.39

103.33

3.3

41.1

35.3

u/l

2.61

6876

39580

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11701

72709

1.35

102.57

9.9

6.5

1.2

mmol/l

100.53

10058

60765

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

185

206

6.60

100.47

7.6

8.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1588

6533

1.83

98.95

3.4

2.5

0.7

0.06

1531

6258

(3024928) Oxygen saturation in Venous blood

875

2898

2.25

98.95

4.1

2.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3488

17645

1.52

97.69

4.2

4.4

252.0

242.9

u/l

2.21

3293

16613

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10741

66371

1.34

94.40

9.1

5.8

1.2

mmol/l

95.21

9875

59414

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1545

6413

1.81

93.36

5.3

3.6

48.0

47.8

0.08

1526

6340

(3020564) Creatinine [Moles/volume] in Serum or Plasma

18820

145605

0.69

91.89

30.3

17.6

93.5

80.9

umol/l

175.12

18813

145551

(3028626) Oxygen [Partial pressure] in Capillary blood

872

2979

2.18

91.43

3.4

2.8

7.8

8.0

kpa

2.39

815

2744

(3026008) Bacteria identified in Urine by Culture

7191

41964

1.36

91.17

3.7

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10400

64208

1.33

90.41

4.9

4.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2230

10341

1.63

90.32

1.8

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7454

43812

1.36

89.95

2.9

2.6

57.4

59.7

u/l

2.34

6927

40068

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18797

145297

0.69

87.94

14.0

10.8

28.6

26.4

u/l

10.48

18169

139139

(3024561) Albumin [Mass/volume] in Serum or Plasma

10218

63125

1.33

87.24

5.8

4.9

33.8

35.0

g/l

68.74

9497

58146

(3007853) Bacteria identified in Skin by Aerobe culture

3163

16062

1.51

85.95

2.2

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

6344

36709

1.36

83.09

5.2

4.0

82.4

87.8

54.47

6196

35908

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2036

9461

1.63

81.35

4.5

3.5

5.1

kpa

2.83

1898

8689

(3015235) Bicarbonate [Moles/volume] in Capillary blood

961

3564

2.01

81.22

3.9

2.9

24.6

24.8

mmol/l

0.96

848

3105

(3038071) Oxygen [Partial pressure] in Mixed venous blood

154

178

6.35

80.96

7.6

8.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

217

354

4.50

79.82

7.2

5.0

25.3

24.9

mmol/l

0.50

186

326

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1984

9218

1.62

79.22

1.8

1.7

—

(3009343) pH of Capillary blood

2004

9346

1.62

78.79

4.5

3.5

7.4

0.74

297

1177

(3026493) Urate [Moles/volume] in Serum or Plasma

6547

38328

1.34

78.47

3.2

2.7

4861.2

5321.4

umol/l

0.35

5629

32790

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1945

9030

1.62

77.83

4.5

3.4

1.7

mmol/l

0.08

1424

6786

(3021901) Oxygen saturation in Capillary blood

746

2561

2.16

77.18

3.4

2.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5083

28809

1.37

74.36

1.9

1.8

1152.1

1139.5

nmol/l

0.41

3951

21146

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1043

4116

1.89

73.53

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

923

3502

1.96

73.08

2.4

2.3

147.6

97.9

ug/min

2.63

568

2008

(3002582) Erythrocytes [#/volume] in Urine

7490

45176

1.31

71.21

3.9

3.3

96.7

95.4

e6/l

0.03

5972

34550

(3000850) Epithelial cells [#/volume] in Urine

5365

31038

1.34

67.56

3.1

2.6

4.8

4.6

e6/l

0.42

4759

27035

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2983

15660

1.45

67.12

2.7

2.9

8.5

10.2

umol/l

4.10

2625

13799

(3044640) Blood type and Crossmatch panel - Blood

7430

45036

1.30

67.02

3.0

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

6888

41432

1.30

65.39

3.8

3.2

0.6

0.4

e6/l

3.04

5399

31005

(21494755) Public health laboratory ask at order entry panel

578

8434

0.49

62.87

1.4

—

(40768804) Tissue Pathology biopsy report

6462

56482

0.77

62.86

2.2

—

(3044889) 12 lead EKG panel

14783

98081

1.28

62.79

5.9

3.7

—

(3010421) pH of Blood

906

3600

1.87

62.42

5.4

3.7

7.4

2.81

793

3062

(1616796) Gas panel - Central venous blood

814

3123

1.93

62.32

4.8

3.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

917

3667

1.86

61.94

3.0

2.3

3.7

g/l

0.17

887

3494

(3027315) Oxygen [Partial pressure] in Blood

816

3156

1.92

61.00

5.4

3.9

8.4

8.5

kpa

0.40

797

3077

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

114

130

6.42

60.74

8.1

6.6

—

(3042936) Bacteria identified in Isolate by Culture

3722

20646

1.38

60.52

2.5

2.0

—

(3012501) Base excess in Blood by calculation

810

3140

1.91

60.14

5.4

3.8

2.4

2.7

mmol/l

1.84

550

2164

(3013290) Carbon dioxide [Partial pressure] in Blood

810

3141

1.91

60.08

5.4

3.8

4.9

5.0

kpa

1.12

791

3063

(3027456) Digoxin [Moles/volume] in Serum or Plasma

754

2874

1.94

58.82

3.0

3.1

0.8

nmol/l

1.35

570

2218

(3018095) Leukocytes [#/volume] in Urine

8240

51234

1.27

58.55

4.4

3.8

107.9

104.0

e6/l

0.14

6283

36852

(36304419) Bacteria [Presence] in Urine

6567

39740

1.29

57.85

3.7

3.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2114

10677

1.49

57.36

5.4

3.6

127.7

88.6

ng/l

36.21

1832

9001

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

16797

130473

0.77

57.11

23.8

14.3

71.6

76.9

ml/min/173m2

166.29

14449

107537

(3006315) Basophils [#/volume] in Blood

10481

67253

1.25

56.01

6.2

5.8

0.0

e9/l

2.70

8925

57129

(40767503) Oxygen content in Capillary blood by calculation

768

3001

1.90

55.65

3.2

2.5

15.7

16.4

3.97

404

1600

(3026782) Osmolality of Urine

4981

29202

1.31

55.23

3.3

2.7

540.5

563.1

mosm/kgh2o

11.31

4327

24751

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

577

2047

2.08

54.86

7.0

6.0

12.1

11.7

mg/l

1.53

535

1884

(3001604) Monocytes [#/volume] in Blood

10406

66847

1.25

54.45

6.2

5.8

0.7

0.6

e9/l

67.72

8854

56741

(3013115) Eosinophils [#/volume] in Blood

10719

69283

1.24

52.13

6.4

6.1

0.2

e9/l

12.89

9277

59579

(3022096) Basophils/100 leukocytes in Blood

9617

61468

1.24

51.61

6.5

6.1

0.6

0.7

11.61

8998

56852

(3019198) Lymphocytes [#/volume] in Blood

10608

68579

1.24

51.07

6.3

5.9

1.9

e9/l

1.31

9170

59200

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

700

9033

0.55

50.86

2.1

1.9

—

(3022806) Fractional oxyhemoglobin in Capillary blood

496

1716

2.13

50.33

2.1

1.8

88.9

89.3

0.66

487

1694

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

768

3100

1.84

50.31

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

768

3101

1.83

50.25

1.4

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

5790

34994

1.28

49.93

1.7

1.5

18.7

20.4

nmol/l

9.80

5066

29307

(3018418) pH of Serum or Plasma

6951

42964

1.26

49.65

5.5

4.1

7.4

1.18

1312

8005

(3006504) Eosinophils/100 leukocytes in Blood

9833

63254

1.23

48.67

6.5

6.1

2.9

0.35

9197

58452

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9559

61313

1.23

48.59

2.2

2.0

91.8

94.4

pmol/l

6.06

5257

32091

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5744

34801

1.27

48.23

2.9

2.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2427

12996

1.41

47.74

2.3

2.7

65.4

66.4

g/l

8.50

2198

11667

(3019069) Monocytes/100 leukocytes in Blood

9873

63628

1.23

47.65

6.9

6.4

9.0

8.9

2.70

9248

59010

(42870588) Differential panel, method unspecified - Blood

7637

47881

1.24

47.59

6.1

5.9

—

(3028271) Lactate [Moles/volume] in Capillary blood

583

2195

1.96

47.13

2.3

1.8

1.7

mmol/l

0.29

568

2143

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

803

3370

1.76

46.25

3.2

2.3

225.4

199.9

11.09

766

3182

(40761511) CBC panel - Blood by Automated count

18271

139682

0.78

46.00

24.4

13.9

—

(3036489) Thrombin time

1042

4711

1.64

45.70

2.7

1.9

22.9

21.5

3.74

957

4175

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

957

11089

0.61

45.67

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2720

14953

1.37

45.55

4.5

3.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2398

12962

1.39

44.45

2.8

2.5

37.1

49.3

u/l

1.57

2052

11127

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

855

3744

1.69

42.33

3.0

2.0

85.7

89.2

4.20

820

3495

(3022313) Gas panel - Capillary blood

1402

6927

1.51

41.84

4.7

3.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

9989

65009

1.21

41.60

6.7

6.2

24.2

26.8

96.82

9288

59887

(3018010) Neutrophils/100 leukocytes in Blood

9830

63955

1.21

40.75

6.4

6.0

60.3

58.0

64.89

9189

59237

(3013650) Neutrophils [#/volume] in Blood by Automated count

11787

78041

1.21

40.71

8.8

9.5

4.8

4.2

e9/l

94.53

10180

67346

(3006184) Hemoglobin [Mass/volume] in Capillary blood

766

3321

1.71

39.33

2.6

2.2

126.3

129.7

g/l

3.01

596

2314

(3040151) Glucose [Moles/volume] in Capillary blood

429

1555

2.03

38.61

13.3

9.6

7.9

7.3

mmol/l

2.56

352

1283

(3022493) Free Hemoglobin [Mass/volume] in Plasma

201

522

2.82

37.74

13.0

2.7

1037.9

2994.9

mg/l

0.75

155

355

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2058

11128

1.38

37.74

3.6

2.7

53.9

64.3

ml/min/173m2

28.01

958

4306

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

406

5646

0.52

37.70

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

751

3279

1.69

37.58

1.5

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

727

3162

1.70

36.90

1.5

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1241

6164

1.50

36.01

1.4

1.6

13.4

16.0

u/ml

0.25

163

(3023183) Ammonium ion [Moles/volume] in Plasma

725

3174

1.69

35.92

2.3

2.8

31.6

34.5

umol/l

2.77

608

2672

(3003434) Protein [Mass/volume] in Pleural fluid

542

2194

1.82

35.22

1.5

1.4

29.5

34.2

g/l

11.95

464

1985

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4320

26136

1.25

34.78

3.2

2.9

1.2

e6/l

0.18

2595

14811

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15868

108818

1.21

34.33

8.8

7.8

82.7

79.9

u/l

8.40

15057

101882

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1056

5128

1.53

34.08

2.4

3.5

40.9

45.7

mg/l

0.62

856

4189

(3052851) Hemolysis interference index of Serum or Plasma

924

4358

1.57

33.98

4.7

3.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

19067

144180

0.79

33.83

32.2

17.3

4.0

mmol/l

185.90

18722

140104

(3044242) Glucose [Moles/volume] in Arterial blood

218

629

2.54

33.53

1.9

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1054

5136

1.52

33.47

2.4

3.5

118.1

60.7

mg/l

0.54

851

4185

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1027

4978

1.53

33.43

2.4

3.4

2.1

3.1

ratio

1.04

343

(3008037) Lactate [Moles/volume] in Venous blood

739

3315

1.65

33.39

4.6

2.9

1.7

1.6

mmol/l

1.08

720

3243

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4052

24458

1.25

33.07

3.4

3.0

2.1

e6/l

0.01

2367

13224

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

462

1825

1.86

32.47

1.6

1.5

—

(3051651) Icteric interference index of Serum or Plasma

256

815

2.31

31.90

5.8

3.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

807

3777

1.58

30.67

2.3

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

19054

143827

0.80

30.25

32.0

17.1

139.4

139.6

mmol/l

42.86

18734

139955

(3019977) pH of Arterial blood

246

790

2.29

30.08

2.4

2.6

7.4

0.62

291

(3035285) Chloride [Moles/volume] in Venous blood

459

1858

1.82

29.89

3.2

2.1

105.4

mmol/l

0.02

454

1848

(3041354) Potassium [Moles/volume] in Venous blood

459

1858

1.82

29.89

3.2

2.1

4.2

4.1

mmol/l

5.14

454

1848

(3013512) EKG study

6887

44235

1.19

29.81

6.3

3.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1231

6358

1.44

29.15

2.0

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

452

1838

1.81

29.01

3.2

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1955

10935

1.33

28.49

2.1

2.5

—

(40758558) Short blood count panel - Blood

5465

34489

1.20

28.36

7.0

7.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

13446

91568

1.17

27.92

5.6

4.6

1131.3

1405.5

e6/l

0.25

247

1412

(3038515) Glucose [Moles/volume] in Venous blood

689

3183

1.60

27.69

4.8

2.9

8.2

7.7

mmol/l

3.97

673

3121

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1140

5861

1.44

27.66

1.9

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

761

3603

1.56

27.53

1.5

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

275

3913

0.51

27.45

1.6

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

493

2096

1.73

27.24

1.5

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

173

500

2.54

26.63

35.5

32.6

7.4

7.2

ug/l

0.47

158

442

(1761868) Lipid panel - Serum or Plasma

5172

43245

0.84

26.16

4.1

3.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

368

1465

1.85

25.35

1.3

1.4

7.0

6.1

mmol/l

6.49

333

1346

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

544

2426

1.65

25.22

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

379

1529

1.82

25.03

1.6

—

(3017569) Oxygen content in Arterial blood

196

620

2.32

24.90

2.0

2.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

461

1975

1.72

24.82

1.5

1382.3

3603.3

e6/l

2.91

339

1430

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

18195

137487

0.83

24.58

7.1

5.0

2.0

2.8

mmol/l

307.65

17085

123847

(3023419) Bacteria identified in Sputum by Culture

433

1828

1.74

24.56

2.1

2.3

—

(3051611) Lipemic interference index of Serum or Plasma

380

1550

1.80

24.23

5.3

3.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

543

2446

1.63

24.21

1.5

1.7

—

(3042733) HLA Ab [Presence] in Serum

141

387

2.67

24.09

5.2

4.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

439

1882

1.72

23.61

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

290

1101

1.93

23.11

1.6

1.5

—

(44806118)

349

1409

1.82

23.03

1.4

1.5

—

(44790047)

349

1410

1.82

22.98

1.4

1.5

—

(44790048)

349

1410

1.82

22.98

1.4

1.5

—

(44790049)

349

1410

1.82

22.98

1.4

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

930

4769

1.44

22.88

1.7

1.6

189.5

281.8

titre

0.62

190

(3021589) Normoblasts [#/volume] in Blood

8924

59461

1.15

22.64

12.8

9.9

0.0

e9/l

1.12

7236

48416

(3001019) Free T4 and TSH panel - Serum or Plasma

286

3782

0.55

22.49

1.7

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4887

40642

0.84

22.46

2.9

3.1

0.8

ug/l

0.34

3490

27724

(3004775) Volume in Urine collected for unspecified duration

301

1170

1.89

22.38

2.3

2.1

678.5

676.5

0.03

205

752

(3045716) Anion gap in Serum or Plasma

179

572

2.29

22.28

2.0

2.5

9.3

9.1

mmol/l

0.22

126

410

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2127

12446

1.27

21.89

1.5

—

(3045788) Cell count panel - Pleural fluid

361

1501

1.77

21.64

1.5

—

(3012441) Differential panel - Pleural fluid

403

1730

1.71

21.61

1.5

—

(4094501)

696

3415

1.50

21.43

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17751

134097

0.85

21.41

6.0

4.8

6.5

6.0

mmol/l

211.50

16245

120083

(40761535) Cells panel - Urine sediment

2041

11934

1.27

21.10

4.1

3.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4820

30748

1.18

21.09

1.8

1.7

47501060.3

29747781.6

pmol/l

0.97

3941

24698

(3000330) Specific gravity of Urine by Test strip

1346

7448

1.34

20.96

4.2

3.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

15692

119601

0.87

20.95

27.4

16.3

38.2

39.7

47.38

9734

79834

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

805

4088

1.45

20.87

1.6

1.4

9.0

14.4

iu/ml

0.96

(3036525) Urea [Moles/time] in 24 hour Urine

5.48

20.87

2.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

198

682

2.13

20.62

2.3

2.1

284.5

84.9

ug/min

0.81

156

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

359

1513

1.74

20.57

1.3

448.5

570.2

u/l

0.43

339

1428

(3028308) Erythrocytes [#/volume] in Pleural fluid

411

1812

1.67

20.00

1.4

1.5

58443.9

62759.5

e6/l

0.08

253

1084

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1129

6127

1.36

19.97

5.1

3.7

24.5

24.9

mmol/l

3.30

1038

5599

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

521

2447

1.57

19.62

1.2

1.3

34.2

39.5

u/l

0.54

459

2099

(3017143) Hepatitis C virus Ab [Presence] in Serum

1944

11436

1.26

19.04

1.8

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1475

13656

0.77

18.93

2.1

2.2

11.9

13.0

nmol/l

5.85

1263

12050

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

724

3680

1.45

18.71

3.5

2.7

2.1

1.6

mg/l

29.96

656

3336

(3011397) Hemoglobin [Presence] in Urine by Test strip

4987

32166

1.17

18.69

4.2

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

605

2976

1.50

18.46

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

284

1165

1.79

17.91

1.2

1.3

1.5

1.3

nmol/l

1.37

255

1058

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1986

11800

1.25

17.81

1.8

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

200

734

2.00

17.69

1.3

1.2

nmol/l

0.56

156

552

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

450

2096

1.58

17.62

1.3

—

(3016750) Collection duration of Urine

215

814

1.94

17.41

2.2

2.0

493.6

493.2

min

0.02

155

574

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1903

11287

1.25

17.32

2.2

2.4

371.3

376.2

nmol/l

0.35

1731

10340

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

423

1951

1.59

17.27

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2323

14090

1.23

17.18

2.1

2.3

0.2

g/l

3.24

2100

13020

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

479

2279

1.54

17.10

5.2

2.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

331

1444

1.68

16.85

3.4

2.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1122

6245

1.33

16.78

2.1

2.3

7.8

7.4

g/l

9.10

822

4589

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1118

6221

1.33

16.76

2.1

2.3

3.8

3.9

g/l

0.46

806

4376

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

694

3575

1.43

16.73

1.6

1.5

1.2

g/l

0.78

655

3378

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

448

2111

1.56

16.71

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

2218

0.50

16.56

1.2

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1056

5839

1.33

16.53

2.1

2.3

10.0

10.3

g/l

1.41

885

4795

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1118

6239

1.32

16.42

2.1

2.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

672

3459

1.43

16.28

1.6

1.5

0.2

g/l

2.14

635

3251

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

559

2783

1.48

16.13

1.3

84.3

162.0

titre

0.99

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

994

5475

1.34

15.98

2.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

227

907

1.83

15.67

1.3

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

428

2.24

15.65

2.9

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

428

2.24

15.65

2.9

2.4

—

(40768806) Pleura Pathology biopsy report

381

1769

1.58

15.19

1.5

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

473

5049

0.68

15.12

3.4

4.0

104.1

81.4

u/ml

0.32

452

4838

(3022621) pH of Urine by Test strip

1551

9126

1.26

15.10

3.4

3.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

326

1461

1.64

15.03

1.2

53.8

62.4

u/l

1.37

210

949

(40768800) Prostate Pathology biopsy report

457

4904

0.67

15.02

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

219

878

1.83

14.98

1.2

11.9

12.2

mmol/l

0.24

306

(3014891) Appearance of Pleural fluid

191

2.87

14.89

1.7

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

843

4587

1.35

14.71

2.1

2.3

0.0

g/l

0.23

769

4149

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1043

5861

1.31

14.60

2.0

2.4

3.2

3.1

g/l

4.06

817

4470

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

806

4376

1.36

14.28

1.9

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

596

3082

1.42

14.13

2.5

2.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

150

3.07

14.05

1.3

1.2

8.3

265332.5

nmol/l

0.91

124

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

17859

133971

0.88

14.04

6.2

4.4

3.8

4.7

mmol/l

307.65

16825

121231

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

792

4305

1.35

13.93

2.1

2.4

0.0

g/l

0.24

720

3877

(4035726)

1559

13850

0.81

13.84

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

291

1295

1.65

13.83

1.9

2.3

0.8

g/24h

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

778

4225

1.36

13.77

2.1

2.4

0.0

g/l

0.00

714

3862

(21494890) Protein electrophoresis panel - 24 hour Urine

355

1664

1.57

13.64

1.6

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

439

2157

1.49

13.59

1.6

1.4

127.3

112.3

u/ml

1.07

456

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

483

2420

1.47

13.57

1.6

1.4

—

(3019150) Specific gravity of Urine by Refractometry

4397

28678

1.15

13.53

5.1

4.1

1.0

kg/l

0.71

774

4368

(3025941) Bacteria identified in Stool by Culture

1139

6550

1.28

13.41

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

876

4863

1.33

13.39

2.0

2.3

36.2

37.4

g/l

6.89

749

4075

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

188

746

1.85

13.35

1.6

1.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1166

6730

1.28

13.33

3.1

3.3

4.2

4.4

pmol/l

8.09

1030

5908

(3002256) Pathology report gross observation

2250

19218

0.84

13.23

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

937

8785

0.77

13.19

2.4

28.7

28.6

au/ml

0.00

365

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.53

13.17

5.8

14.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

340

3767

0.65

13.16

2.4

1.6

4.7

3.6

mg/l

0.73

270

2702

(3052592) Norovirus Ag [Presence] in Stool

265

2.46

13.15

1.5

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

650

3457

1.38

13.13

1.6

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

13708

95644

1.11

13.05

5.2

4.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

837

7928

0.76

12.74

1.3

48.2

52.7

au/ml

0.22

365

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

632

6218

0.73

12.56

1.2

—

(3035880) pH of Pleural fluid

210

881

1.75

12.45

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1285

7569

1.25

12.40

1.7

2.0

1.2

1.4

g/l

1.81

1171

6797

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

539

2807

1.41

12.34

1.8

1.6

0.9

0.8

nmol/l

2.35

440

2354

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

473

2407

1.44

12.30

1.6

1.4

21.1

14.8

u/ml

—

(3017704) Immunofixation for Urine

206

864

1.75

12.23

1.3

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

185

752

1.80

12.21

2.0

2.3

21.8

34.3

umol/l

0.66

(3037756) Immunofixation for Serum or Plasma

647

3481

1.37

12.20

1.4

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1349

0.45

12.18

1.3

1.4

66.6

98.4

pmol/l

0.66

423

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

935

5328

1.29

11.85

2.1

2.5

0.7

1.0

g/l

2.49

800

4454

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

271

2.35

11.72

1.2

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

613

3297

1.37

11.60

1.2

865.0

951.9

titre

0.17

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

146

560

1.91

11.57

1.5

1.4

61.9

62.0

0.01

112

464

(3014765) Yersinia sp identified in Stool by Organism specific culture

646

3507

1.35

11.53

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

646

3516

1.35

11.34

1.2

—

(40768793) Breast Pathology biopsy report

203

2438

0.60

11.33

1.2

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

9634

66309

1.10

11.19

4.4

3.6

0.0

estimate

0.75

1776

11783

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5464

36501

1.12

11.18

1.8

1.6

1.4

mmol/l

1.67

4573

29991

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

639

3481

1.35

11.16

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

615

3334

1.36

11.09

1.2

94.5

137.6

titre

0.67

270

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

373

1852

1.48

11.07

1.4

1.3

0.2

0.3

nmol/l

1.05

144

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

576

3096

1.37

10.97

1.4

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

186

785

1.73

10.87

11.9

9.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.03

10.64

4.5

2.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

232

1046

1.62

10.60

1.2

134.3

138.7

titre

0.03

181

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

346

1708

1.49

10.59

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1309

7864

1.23

10.56

2.6

2.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.21

10.54

13.5

9.1

152.9

205.2

e6/l

0.28

(43055442) Apixaban [Mass/volume] in Serum or Plasma

191

2.53

10.44

1.6

1.4

137.9

114.7

ug/l

0.82

145

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

231

1046

1.62

10.39

1.2

88.6

156.3

titre

—

(3025315) Body weight

106

3.10

10.31

5.9

4.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

369

1856

1.46

10.29

1.4

1.3

3.5

1.7

nmol/l

0.27

353

1776

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

931

1.65

10.27

1.6

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

175

741

1.73

10.15

3.7

3.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2346

19562

0.86

10.09

5.9

4.6

33.1

31.9

5.94

1888

12453

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

524

2819

1.36

9.97

6.1

5.3

2450.3

1142.3

iu/ml

0.36

441

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

17757

132645

0.90

9.93

6.1

4.4

1.3

1.4

mmol/l

307.65

16607

119193

(3010375) cycloSPORINE [Mass/volume] in Blood

146

590

1.81

9.92

23.4

29.7

108.4

116.9

ug/l

0.71

104

508

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

6.57

9.91

7.6

8.8

41.6

52.9

—

(3000492) Spirometry study

1855

11598

1.18

9.78

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

262

1242

1.55

9.74

1.2

1.3

12.9

14.2

u/l

0.33

231

1150

(46235355) HIV 1 and 2 tests - Meaningful Use set

2162

13698

1.17

9.68

1.8

1.5

—

(3011985) Renin [Units/volume] in Plasma

351

1771

1.45

9.66

1.3

1.4

85.9

60.0

mu/l

1.12

313

1568

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

189

830

1.67

9.62

1.2

1.3

109.8

93.1

u/l

1.04

165

710

(3037522) Nuclear Ab [Titer] in Serum

2488

15975

1.15

9.31

1.3

529.6

521.9

titre

0.07

587

3388

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

183

806

1.66

9.23

1.3

31.0

27.0

u/l

0.39

155

678

(3009261) Glucose [Presence] in Urine by Test strip

9706

67274

1.09

8.96

4.5

3.7

0.0

estimate

0.06

1651

11724

(3012565) Volume of 24 hour Urine

158

675

1.71

8.94

2.1

2.2

1753.1

1968.8

1.78

134

590

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

382

1992

1.41

8.83

1.2

311.4

280.0

u/ml

0.94

257

1237

(3003338) MCHC [Mass/volume]

14625

110084

0.92

8.82

33.2

19.4

330.9

332.7

g/l

91.94

14458

109262

(40768446) Kidney Pathology biopsy report

127

511

1.82

8.81

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

471

4569

0.75

8.62

1.7

41.7

43.4

nmol/l

1.04

451

4415

(40757373) Influenza virus identified in Isolate

276

2.12

8.60

1.5

1.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

876

1.60

8.47

1.6

1.5

6.1

6.3

u/l

0.06

404

(3017181) Myelocytes/100 leukocytes in Blood

1871

11853

1.16

8.38

4.0

4.1

0.8

1.0

2.03

592

3749

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.65

8.30

6.1

4.8

440.4

432.8

umol/l

0.06

(3003181) Sodium [Moles/volume] in Urine

498

2738

1.33

8.30

1.4

1.3

60.1

61.9

mmol/l

0.48

403

2174

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

181

820

1.62

8.24

1.7

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

313

1596

1.44

8.23

1.4

1.3

—

nmol/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

9572

66476

1.09

8.17

5.9

4.9

0.0

estimate

1.08

1805

12033

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1323

8162

1.19

8.16

3.4

2.8

0.4

0.3

e6/l

1.01

1301

8007

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

180

817

1.61

8.14

1.7

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

634

1.70

8.09

1.2

—

(3016038) Potassium [Moles/volume] in Urine

206

970

1.55

7.99

1.2

1.1

35.2

34.0

mmol/l

0.27

177

810

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.84

7.95

8.8

9.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

181

828

1.60

7.94

1.5

1.4

16.5

13.6

umol/l

3.95

163

781

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

141

605

1.70

7.91

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

199

932

1.56

7.90

2.9

2.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

546

3067

1.31

7.85

1.5

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

231

2.15

7.65

1.5

1.4

13.1

11.5

0.20

121

(3005719) IgG [Mass/volume] in Serum or Plasma

1545

9726

1.17

7.52

2.5

2.9

10.6

10.7

g/l

0.22

1429

8813

(3044927) Protein electrophoresis panel - Urine

323

1686

1.40

7.50

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

317

1653

1.40

7.41

1.3

1.2

5.1

3.7

u/ml

0.87

141

720

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

396

2151

1.35

7.22

1.2

—

(3025159) Blasts/100 leukocytes in Blood

1645

10453

1.16

7.10

4.1

0.1

0.3

1.81

468

2928

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

100

402

1.82

7.06

1.3

1.4

20.4

23.1

0.45

341

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

127

549

1.69

7.00

4.4

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

594

3429

1.27

6.96

1.9

2.0

13.2

11.5

mg/l

1.26

550

3159

(3021440) Promyelocytes/100 leukocytes in Blood

1758

11244

1.15

6.94

4.0

4.1

0.1

2.34

552

3488

(3002179) Metamyelocytes/100 leukocytes in Blood

1679

10708

1.16

6.90

3.9

0.6

0.7

1.51

418

2714

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

167

1861

0.65

6.88

3.2

3.6

34.0

40.3

u/ml

0.40

154

1806

(1761482) Bacteria [#/volume] in Urine by Culture

702

4146

1.24

6.77

5.0

4.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

316

1677

1.38

6.71

1.2

1.4

228.4

288.2

pmol/l

1.65

236

1273

(3024932) HLA-DR beta [Type]

101

416

1.77

6.61

1.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

407

1.78

6.53

1.9

1.8

178.7

169.2

0.50

382

(3006442) Creatine [Moles/volume] in Serum or Plasma

184

888

1.52

6.48

1.6

73.3

72.2

umol/l

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

232

1176

1.44

6.41

1.4

14.4

12.6

u/l

3.72

226

1127

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

134

604

1.62

6.34

2.3

3.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

154

720

1.56

6.27

1.2

1.1

45.8

25.3

u/l

1.18

119

536

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1210

7591

1.17

6.19

1.4

—

(3024471) HLA-A [Type]

102

432

1.73

6.11

1.0

—

(3037121) Protein [Mass/volume] in Urine

848

5166

1.21

6.08

2.9

3.2

0.4

0.3

g/l

3.08

412

2345

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1840

11918

1.14

6.06

5.6

3.8

1.2

mmol/l

14.44

1651

10276

(3001893) Eosinophils/100 leukocytes in Pleural fluid

112

489

1.67

6.02

1.5

1.4

3.4

2.7

0.36

414

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

153

722

1.55

6.00

1.2

1.1

125.5

84.6

u/l

1.95

122

559

(3042631) Mycobacterium sp identified in Specimen

398

2231

1.31

5.93

2.6

2.7

—

(40768797) Stomach Pathology biopsy report

2851

18971

1.11

5.92

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

275

1459

1.38

5.91

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

197

2.08

5.87

1.4

1.2

84.6

84.4

0.02

(3041918) Cholesterol [Moles/volume] in Pleural fluid

288

1.88

5.85

1.2

1.4

1.8

mmol/l

1.40

170

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

278

1.89

5.83

2.7

2.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

115

511

1.64

5.80

1.8

83.4

106.3

umol/l

0.73

259

(3024980) IgG subclass 4 [Mass/volume] in Serum

357

1980

1.32

5.75

1.6

0.8

0.9

g/l

0.66

270

1458

(1617658) Protocol used for examination of sentinel lymph nodes

869

0.54

5.68

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

375

2099

1.31

5.67

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

156

750

1.52

5.66

1.3

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

256

1.91

5.61

3.0

3.5

14.5

14.7

ml/dl

0.24

244

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

196

2.05

5.59

1.5

1.2

75.0

77.1

0.14

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

12.16

5.59

1.1

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

134

2.29

5.58

1.4

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

631

0.47

5.56

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

149

712

1.53

5.56

1.2

1.1

3.1

3.3

iu/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

285

1537

1.36

5.56

3.2

3.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

101

439

1.68

5.55

1.4

1.3

22.9

21.6

0.18

397

(4010399)

1556

10027

1.14

5.55

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

5231

35885

1.08

5.54

5.0

4.1

0.0

estimate

0.08

1624

11410

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

352

1.76

5.54

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

137

1514

0.66

5.52

1.2

—

(3008898) HLA-B27 [Presence]

298

2883

0.75

5.51

1.1

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

306

1671

1.34

5.51

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

710

4297

1.21

5.49

1.4

249.9

260.9

ug/g

0.76

452

2569

(3000012) Reticulocyte production index

177

880

1.47

5.48

1.6

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

138

1519

0.66

5.46

1.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

281

2736

0.75

5.44

1.2

1.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

174

2.10

5.41

1.1

1.6

—

12.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1760

14339

0.89

5.29

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

381

2159

1.29

5.29

2.7

2.6

763.3

7344.6

u/ml

0.96

146

(3048929) Epstein Barr virus Ab [Presence] in Serum

472

2751

1.26

5.22

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

194

992

1.43

5.21

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

300

1649

1.33

5.19

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

135

1474

0.67

5.16

1.2

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

760

4666

1.19

5.08

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

686

4173

1.21

5.07

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

529

4718

0.81

5.03

1.4

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

520

1.59

5.02

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

231

1230

1.37

4.94

2.1

1.9

2.5

u/field

0.82

478

(40760892) CBC W Ordered Manual Differential panel - Blood

3965

27025

1.08

4.88

5.1

4.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16343

121522

0.93

4.86

5.0

4.5

2.1

mu/l

0.33

14878

108609

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

192

1.98

4.86

1.2

51.2

447.6

u/l

0.92

132

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

345

1.72

4.85

4.8

6.3

69.4

70.3

0.11

272

(3017732) Neutrophils [#/volume] in Blood

1146

9537

0.87

4.81

3.5

3.0

4.7

4.1

e9/l

7.89

828

6926

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

306

1711

1.31

4.74

1.3

1.2

3.3

4.5

u/ml

0.67

110

595

(3008116) Ketones [Moles/volume] in Urine by Test strip

267

1.81

4.71

1.4

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

376

1.67

4.70

1.5

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7249

55244

0.94

4.69

4.3

23.1

21.6

12.52

3524

27972

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

365

3358

0.79

4.64

1.3

626.3

582.4

mg/l

0.34

342

3188

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17882

128339

1.07

4.61

8.5

6.0

43.9

40.0

mmol/mol

307.65

16796

116476

(3045414) Leukocytes [Presence] in Urine

976

6172

1.16

4.60

2.2

1.9

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

181

1.98

4.59

1.2

1.4

75.9

70.0

0.68

148

(3006270) Folate [Moles/volume] in Blood

224

1205

1.36

4.53

1.2

310.2

340.6

nmol/l

1.24

164

993

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

105

489

1.57

4.48

2.0

1.9

19134.1

9090.7

e6/l

0.74

269

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.75

4.47

1.2

11343.8

2120.8

ng/l

0.93

(4268621)

205

1090

1.38

4.47

2.4

2.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.72

4.45

4.1

3.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

102

1139

0.65

4.42

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

284

1.75

4.40

1.2

—

(1002224) Polysomnography panel

522

4594

0.82

4.39

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

449

2663

1.23

4.33

1.5

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

388

2265

1.25

4.31

1.7

1.9

25.2

24.6

ug/l

0.07

377

2220

(3023383) Lactate [Moles/volume] in Pleural fluid

113

542

1.52

4.26

1.3

3.1

3.6

mmol/l

1.19

501

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

4.86

4.17

7.5

7.3

9314.1

180.5

e6/l

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

306

1.69

4.14

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

306

1.69

4.14

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

306

1.69

4.14

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

306

1.69

4.14

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

257

1.76

4.14

1.1

1.2

0.8

41.8

mg/l

1.01

200

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.38

4.12

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

190

1013

1.37

4.11

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

341

1976

1.26

4.07

1.1

582.6

5882.5

iu/ml

0.47

402

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

128

1341

0.69

4.03

1.1

—

25.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

484

4252

0.83

4.03

1.3

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

175

1.92

4.01

4.7

4.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

100

474

1.54

4.00

3.1

2.1

26.2

481.0

ug/l

1.29

445

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1040

0.66

3.95

4.1

5.4

31.9

93.4

u/ml

2.60

318

(3020491) Glucose [Moles/volume] in Blood

183

979

1.37

3.90

2.2

1.9

7.5

7.1

mmol/l

1.12

135

655

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

796

0.61

3.89

5.3

6.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

869

5525

1.15

3.87

1.8

1.9

36.3

39.1

u/l

3.28

713

4795

(3034274) Bile acid [Moles/volume] in Serum --fasting

101

484

1.52

3.86

1.2

1.4

8.7

15.6

umol/l

1.52

341

(4306422)

285

1627

1.28

3.86

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

625

5345

0.85

3.85

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

151

1524

0.72

3.84

1.5

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

227

1258

1.32

3.84

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

227

1258

1.32

3.84

1.3

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

227

1258

1.32

3.84

1.3

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

185

995

1.36

3.82

1.3

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

410

1.57

3.81

1.4

1.3

17.0

12.1

g/l

5.88

309

(3027135) IgG subclass 1 [Mass/volume] in Serum

223

1234

1.32

3.81

1.3

1.4

6.9

7.0

g/l

0.13

158

817

(3033923) Metanephrine [Moles/time] in 24 hour Urine

253

1.73

3.81

1.1

0.7

umol/24h

0.07

123

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

376

1.59

3.80

1.1

—

(4062490)

223

1235

1.32

3.79

1.3

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

184

1.87

3.79

2.4

2.3

90.8

59.5

mg/l

0.37

(4281824)

135

1382

0.71

3.75

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

141

727

1.42

3.75

2.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

151

789

1.40

3.72

2.3

1.9

2.0

2.3

u/field

0.24

104

554

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

118

1234

0.70

3.72

1.5

1.9

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

222

1233

1.32

3.71

1.3

1.4

0.4

g/l

0.49

161

820

(3049717) Cytology report of Urine Cyto stain

1072

6935

1.13

3.71

2.7

2.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

198

1082

1.34

3.70

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

222

1234

1.32

3.69

1.3

1.4

2.9

3.0

g/l

0.51

159

817

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

266

1517

1.28

3.66

1.4

1.8

—

(3006462) Nitrate [Presence] in Urine

131

672

1.42

3.60

3.4

3.6

—

(4211845)

140

727

1.41

3.59

3.3

3.5

—

(3025130) Human papilloma virus identified in Specimen

761

0.62

3.58

1.6

—

(4034850)

692

4357

1.16

3.54

15.9

9.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

250

1421

1.29

3.54

1.4

1.8

—

(3019225) pH of Specimen

2031

16067

0.91

3.51

5.6

4.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3990

27523

1.07

3.51

3.1

3.4

2.5

mmol/l

2.28

3370

24107

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

220

1232

1.31

3.49

1.3

1.1

90.9

96.5

2.53

210

1120

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

496

3044

1.19

3.47

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

277

1600

1.27

3.46

1.2

1.1

110.0

116.0

1.91

246

1421

(3023487) Leukocytes [#/volume] in Peritoneal fluid

112

564

1.45

3.42

2.1

2.0

13649.8

1076.5

e6/l

0.88

390

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

193

1065

1.32

3.41

1.1

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

364

1.57

3.40

1.4

1.3

29.1

44.4

g/l

0.43

274

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2203

17339

0.92

3.39

3.4

4.3

14.8

27.2

ug/l

2.19

1820

14484

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

329

2945

0.81

3.38

1.2

1.3

4.2

3.8

mmol/l

5.93

307

2771

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

196

1086

1.32

3.37

2.2

2.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

297

1737

1.25

3.35

1.1

1.7

1.5

g/l

4.68

266

1559

(3002523) Influenza virus A Ag [Presence] in Specimen

127

1285

0.72

3.34

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

151

0.29

3.28

2.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

151

0.29

3.28

2.2

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

128

1288

0.72

3.26

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.39

3.20

1.1

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

193

1077

1.31

3.18

1.4

1.3

1.4

promille

0.37

142

844

(3042010) Triglyceride [Moles/volume] in Pleural fluid

229

1.69

3.15

1.2

0.4

1.6

mmol/l

2.21

145

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7161

50404

1.05

3.14

4.9

3.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

150

0.29

3.12

2.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

150

0.29

3.12

2.2

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

681

4331

1.15

3.10

1.2

1.1

1.0

u/ml

0.06

379

(40763791) Oxygen content in Venous blood by calculation

3.24

3.08

6.0

5.7

12.0

11.9

ml/dl

0.04

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

422

0.54

3.08

2.1

2.5

123.9

146.9

nmol/l

0.60

359

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

381

3327

0.83

3.07

1.8

1.9

191.7

201.2

pmol/l

1.24

360

3125

(3017315) Amylase [Enzymatic activity/volume] in Urine

137

731

1.37

3.06

1.2

342.4

391.3

u/l

0.18

132

679

(3009871) Measles virus Ab [Titer] in Serum

335

1.55

3.00

1.4

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

683

4357

1.15

2.99

1.7

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

326

2879

0.82

2.98

1.3

1.4

600.7

2154.0

e6/l

1.27

280

2323

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

143

1392

0.75

2.97

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

206

1172

1.28

2.97

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

527

0.59

2.94

1.4

—

(3044007) Cell count panel - Peritoneal fluid

445

1.46

2.88

2.2

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

327

2873

0.83

2.85

1.3

1.4

19.4

33.4

e6/l

0.83

265

2197

(3033799) Differential panel - Peritoneal fluid

501

1.43

2.83

1.9

—

(3028300) Cannabinoids [Presence] in Urine

196

1817

0.79

2.83

1.7

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

208

1910

0.79

2.78

1.3

1.4

30.5

32.2

iu/l

0.25

177

1607

(3027008) Opiates [Presence] in Urine

196

1812

0.79

2.77

1.7

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

376

2303

1.19

2.77

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

162

902

1.31

2.77

1.2

—

(3005033) Fetal Nuchal fold Thickness US

126

0.29

2.75

2.2

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

281

0.47

2.74

1.2

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

195

1801

0.79

2.74

1.7

2.0

—

(3044941) Cell count panel - Synovial fluid

391

2406

1.19

2.74

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

127

0.29

2.74

2.2

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

396

1.48

2.74

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

128

0.28

2.73

2.2

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

335

2034

1.20

2.72

2.3

2.1

20.2

28.6

mg/l

2.65

529

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

314

1.53

2.72

2.0

2.4

7.9

7.7

mmol/l

0.18

193

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

150

0.34

2.71

1.9

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

813

0.69

2.68

1.3

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

346

1.50

2.63

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

503

1.41

2.62

1.5

1.7

4.3

9.5

nmol/l

0.58

435

(3004809) Band form neutrophils/100 leukocytes in Blood

432

2694

1.17

2.61

3.3

3.5

1.4

1.5

0.40

339

2064

(3002619) Bacteria identified in Specimen by Culture

300

1.53

2.60

1.4

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

171

1.71

2.53

4.8

42.7

48.3

ug/min

0.34

146

(3027944) Amphetamines [Presence] in Urine

194

1771

0.80

2.50

1.7

1.9

—

(44786800) Granulocytes/100 leukocytes in Body fluid

211

1.63

2.49

1.3

1.4

20.8

27.5

0.82

170

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

286

1.53

2.48

1.2

1.1

75.8

85.0

1.13

144

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

566

3617

1.15

2.48

1.8

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

485

0.62

2.48

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

166

0.40

2.47

1.6

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

103

1.91

2.45

3.0

5.3

—

(3022145) Colonoscopy Study observation

2063

16061

0.93

2.45

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

233

1381

1.23

2.44

3.4

3.0

107.3

44.2

mg/l

1.39

175

1008

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

109

1068

0.74

2.44

1.2

1.3

2.3

2.2

mmol/l

0.61

999

(3015377) Calcium [Moles/volume] in Serum or Plasma

6909

48839

1.05

2.43

3.4

3.6

2.3

2.4

mmol/l

9.02

5926

41713

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

114

1.86

2.42

1.7

2.2

0.7

1.0

mmol/l

0.56

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

275

1660

1.21

2.42

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

589

3782

1.14

2.42

1.6

17547.2

15363.4

e6/l

0.45

414

2723

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

708

0.69

2.38

1.1

1.4

0.1

0.2

nmol/l

0.87

505

(3039162) Centromere protein B Ab [Units/volume] in Serum

230

1366

1.23

2.38

1.3

1.2

55.7

49.8

u/ml

0.13

(3016650) Hepatitis A virus Ab [Presence] in Serum

315

1930

1.19

2.37

1.1

—

(3016879) Cocaine [Presence] in Urine

187

1701

0.80

2.36

1.7

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

446

1.41

2.36

1.2

1.1

1.7

15.2

u/ml

—

(3003694) ABO and Rh group [Type] in Blood

4726

35845

0.95

2.33

1.3

—

(3034426) Prothrombin time (PT)

381

1.44

2.31

1.4

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

116

1.82

2.31

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

280

1.51

2.29

1.2

68.5

84.7

1.92

144

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

581

1.35

2.24

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

206

1.59

2.24

1.4

1.2

75.6

571.7

ng/l

0.67

136

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

134

752

1.30

2.24

1.3

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

158

0.42

2.23

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

134

753

1.30

2.22

1.3

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

497

3177

1.14

2.21

4.4

3.4

28.1

28.9

mg/l

0.18

354

1986

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

207

1.59

2.20

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

340

2114

1.18

2.19

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

129

1.75

2.19

1.9

1.6

57.1

42.9

umol/l

1.22

129

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

196

1.60

2.19

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

136

768

1.29

2.18

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

136

768

1.29

2.18

1.3

1.5

—

(3045424) Erythrocytes [Presence] in Urine

284

2457

0.84

2.18

1.7

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3135

21787

1.06

2.18

1.5

2.8

2.7

g/l

1.60

1814

12577

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

207

0.46

2.16

2.7

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

258

2247

0.84

2.14

1.5

1.8

287.5

279.7

mu/l

0.15

236

2088

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

836

0.73

2.13

1.1

46.4

48.2

mg/l

0.13

712

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

792

0.73

2.11

1.1

359.7

335.0

mg/l

0.31

704

(1001926) Buprenorphine [Presence] in Urine by Screen method

151

1385

0.79

2.09

1.9

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

439

3659

0.87

2.09

2.8

3.5

1410.6

600.4

u/ml

0.67

394

3326

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

495

1.36

2.07

1.3

244.3

310.0

ug/l

0.20

276

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

126

1.74

2.07

1.1

13.6

14.8

iu/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

203

1211

1.22

2.06

1.1

—

(3003129) Base excess in Capillary blood by calculation

410

1.39

2.03

1.5

1.7

0.3

0.6

mmol/l

0.32

387

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

5.21

2.01

1.0

—

(3014271) Vancomycin [Susceptibility]

168

985

1.25

2.01

3.4

2.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9269

69121

0.96

2.01

4.8

5.1

3.1

3.5

ug/l

0.48

8178

62210

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

304

0.58

1.97

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

456

1.36

1.97

1.6

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.19

1.95

1.0

112.4

192.8

pmol/l

—

(3023410) Appearance of Cerebral spinal fluid

142

1299

0.80

1.95

1.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

128

0.40

1.94

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

102

1.79

1.91

1.5

1.8

1.4

0.8

0.35

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

609

0.71

1.91

1.1

1.3

1.1

u/l

0.68

327

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

781

6258

0.91

1.91

1.2

134.1

132.9

iu/ml

0.02

263

2146

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

339

2136

1.16

1.90

1.2

27.5

48.3

u/ml

2.31

208

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

390

0.64

1.88

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

614

0.71

1.86

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

206

1248

1.21

1.84

1.7

1.4

45.0

25.2

iu/ml

0.63

(3001729) Color of Synovial fluid

120

1.70

1.83

1.4

1.7

—

(3022689) Creatine [Moles/volume] in Urine

407

1.36

1.81

1.4

1.5

—

(3020650) Glucose [Presence] in Urine

323

0.61

1.80

1.4

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

321

1.41

1.79

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

358

1.39

1.79

1.2

1.3

0.3

g/l

0.83

292

(44806420)

464

1.34

1.79

2.2

2.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

197

1192

1.21

1.79

1.6

20.7

26.4

u/ml

1.23

256

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

371

1.38

1.78

1.4

16.7

16.0

pmol/l

0.20

302

(3011335) Digoxin [Mass/volume] in Serum or Plasma

116

1.70

1.76

1.7

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

453

0.68

1.75

1.1

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.75

1.5

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.21

1.74

1.0

1.1

0.1

0.2

g/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

125

1141

0.80

1.73

1.0

43.7

43.2

ng/l

0.05

784

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.07

1.72

1.1

258.2

251.8

nmol/l

0.07

(3010726) Horse dander IgE Ab [Units/volume] in Serum

114

1050

0.79

1.71

1.1

1.0

1.8

u/ml

0.02

236

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

125

1139

0.80

1.70

1.0

761.2

715.6

ng/l

0.48

765

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

157

1.58

1.70

1.3

1.1

15.3

19.5

u/l

1.14

106

(3006969) Lambda light chains [Mass/volume] in Urine

2.25

1.67

1.0

1.1

0.0

g/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

345

1.38

1.66

1.2

1.3

113.5

114.3

0.08

303

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

496

1.31

1.65

1.6

1.7

166697.5

21219.2

u/ml

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

125

1133

0.80

1.64

1.0

320.8

331.0

ng/l

0.16

793

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

385

0.66

1.63

1.2

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

155

0.47

1.61

1.0

1.2

48.8

69.3

u/ml

—

149

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

562

3704

1.11

1.61

1.6

10.1

2.2

iu/ml

0.43

138

819

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

167

1007

1.21

1.61

1.3

158.6

513.9

titre

1.82

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

157

941

1.22

1.60

2.5

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

294

1862

1.15

1.59

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9140

67972

0.97

1.59

2.5

2.3

—

(4146454)

292

1850

1.15

1.58

3.0

2.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

595

0.73

1.58

1.1

456.6

397.3

ng/l

0.09

152

(3018133) Calcium [Moles/volume] in Urine

149

1.57

1.2

1.6

2.6

2.7

mmol/l

0.11

131

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

131

773

1.24

1.56

1.1

—

(3047189) Immunofixation for 24 hour Urine

129

760

1.24

1.56

1.4

1.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

131

774

1.24

1.54

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

1.53

0.0

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

127

1139

0.81

1.53

1.9

2.0

5.3

3.5

ug/l

0.79

113

1000

(3005322) IgE [Units/volume] in Serum or Plasma

969

6565

1.08

1.53

1.3

254.9

289.0

u/ml

0.37

887

6043

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

139

1.58

1.51

2.1

2.2

63.1

58.5

0.26

(3032057) Clostridioides difficile [Presence] in Stool

339

1.36

1.50

2.3

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

220

1371

1.17

1.49

1.3

—

42.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

795

0.78

1.49

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

483

3174

1.11

1.48

1.2

62.2

39.7

u/ml

0.81

179

(3037692) Legionella sp identified in Specimen by Organism specific culture

550

1.27

1.48

1.3

1.5

—

(40758292) HTLV I+II Ab panel - Serum

234

0.59

1.47

1.2

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.78

1.47

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

512

0.73

1.47

1.0

1.1

4.3

4.8

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

495

0.72

1.47

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

349

0.67

1.46

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11552

85519

0.97

1.46

3.6

3.2

66.2

55.5

u/l

16.27

10639

78265

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.92

1.45

10.8

8.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

735

0.77

1.45

1.0

2.3

0.4

u/ml

0.48

187

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.32

1.45

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

164

1.51

1.45

5.3

2.6

1.5

1.1

mg/l

0.68

123

(3010144) Erythrocytes [#/volume] in Synovial fluid

237

1490

1.16

1.45

1.4

141195.0

116624.7

e6/l

0.21

165

1008

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

393

2560

1.12

1.42

1.2

7.3

10.9

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

381

0.69

1.42

1.1

1.0

0.5

0.6

u/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

139

836

1.21

1.41

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

780

0.78

1.40

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

380

0.69

1.40

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.78

1.40

2.9

1.3

23.0

22.8

mmol/l

0.07

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

763

0.78

1.39

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

451

2967

1.11

1.38

1.3

7.6

5.8

u/ml

0.36

486

(3024522) Salmonella sp identified in Specimen by Organism specific culture

292

1872

1.14

1.38

1.3

1.4

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

1.37

0.0

1.4

—

403.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

377

0.70

1.35

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2671

18733

1.05

1.35

11.9

6.7

—

(40762887) Creatinine [Moles/volume] in Blood

2.19

1.34

1.1

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

310

2002

1.13

1.32

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

324

2657

0.89

1.32

1.3

1.4

10.2

9.0

u/l

0.80

256

2119

(3014133) Dog dander IgE Ab [Units/volume] in Serum

886

0.81

1.32

1.1

1.0

4.5

3.2

u/ml

0.29

333

(3024263) Appearance of Synovial fluid

135

818

1.21

1.30

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

160

986

1.19

1.28

1.3

196.0

62.7

titre

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

850

0.81

1.28

1.3

2.1

15.9

16.0

nmol/l

0.07

781

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.42

1.27

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

297

1919

1.13

1.27

1.3

1.4

—

(40768443) Skin Pathology biopsy report

844

6600

0.93

1.26

1.2

—

(3019174) dRVVT (LA screen)

1.66

1.26

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

111

1.58

1.25

1.8

2.1

14.2

17.0

0.20

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

162

1388

0.85

1.25

1.1

2.7

1.1

u/ml

0.59

546

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

379

0.71

1.25

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.71

1.25

1.5

1.1

—

(21494434) Karyotype in Bone marrow

224

1422

1.15

1.25

1.1

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.81

1.25

1.2

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

443

2939

1.10

1.19

1.3

1.2

8.5

6.1

u/ml

0.23

323

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

123

746

1.20

1.19

1.5

1.4

7.8

5.6

u/l

0.98

106

617

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

383

0.72

1.18

1.3

2.4

1.4

1.0

ug/l

0.48

358

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

146

1254

0.85

1.18

1.1

7.1

3.9

u/ml

0.50

466

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

381

2511

1.11

1.18

1.2

2.6

5.7

u/ml

1.19

189

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

1.17

0.0

5.9

—

0.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

139

1197

0.85

1.16

1.8

2.2

44.6

37.4

1.29

146

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

182

0.60

1.15

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.96

1.15

1.0

1.1

—

mmol/l

—

(3036603) Volume of Urine

160

998

1.17

1.14

1.6

1679.2

1975.3

1.40

234

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

130

1122

0.84

1.12

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

193

1.40

1.12

3.4

3.2

42.1

41.4

umol/l

0.06

165

(3013166) Neutrophils/100 leukocytes in Synovial fluid

461

1.25

1.12

1.5

1.4

68.9

56.1

2.89

390

(3015183) Erythrocyte sedimentation rate

454

0.75

1.12

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

120

1042

0.84

1.11

2.0

2.5

483.4

597.0

e6/l

1.50

433

(3050794) Legionella sp Ab [Presence] in Serum

115

1.52

1.10

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

121

1.51

1.10

1.2

1.1

1.9

1.8

umol/24h

0.25

121

(3023430) Cat dander IgE Ab [Units/volume] in Serum

833

0.82

1.09

1.1

1.0

1.3

2.8

u/ml

1.39

314

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

777

0.82

1.09

3.8

5.7

54.8

5327.6

u/ml

—

148

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7633

54713

1.03

1.09

2.4

2.2

75.7

78.9

nmol/l

18.05

6672

47956

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

368

0.73

1.08

1.1

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

392

0.74

1.06

1.1

1.0

0.5

1.1

u/ml

1.01

112

(3025468) Yersinia sp identified in Specimen by Organism specific culture

283

1848

1.12

1.06

1.3

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

125

770

1.19

1.06

3.7

3.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

132

0.55

1.06

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

283

1849

1.12

1.05

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

772

6008

0.94

1.05

2.9

3.6

1833.6

1322.5

u/ml

0.28

640

5216

(44816559) Phosphatidylethanol [Mass/volume] in Blood

317

2085

1.11

1.05

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

368

1.27

1.04

1.4

1.6

9.8

9.4

ug/l

0.37

368

(3025577) Chromium [Mass/volume] in Blood

129

1104

0.85

1.03

2.0

2.1

2.9

2.2

ug/l

0.54

108

921

(3045683) HLA typing for celiac disease panel - Blood or Tissue

505

0.78

1.03

1.1

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.46

1.03

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

258

1680

1.12

1.03

1.4

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

176

0.62

1.03

1.1

1.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

579

1.21

1.03

2.2

2.3

62.4

56.1

umol/l

1.01

476

(3005988) Vibrio sp identified in Specimen by Organism specific culture

283

1853

1.12

1.02

1.3

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

382

1.26

1.02

1.4

1.3

28.2

34.9

0.87

254

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

241

1.33

1.02

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.55

1.01

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

281

1842

1.11

1.00

3.4

3.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

165

0.62

0.98

6.0

5.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

186

1.37

0.98

3.7

2.7

0.3

0.5

u/field

0.99

186

(3015076) Soybean IgE Ab [Units/volume] in Serum

328

0.73

0.98

1.1

1.0

0.7

0.3

u/ml

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.96

0.96

1.1

1.6

—

(40765096) Chromosome analysis panel by Banding

507

0.79

0.95

1.1

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

539

0.80

0.95

1.4

1.5

26.5

29.5

umol/l

1.60

520

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

359

0.75

0.94

1.6

1.5

0.5

0.4

ug/l

0.58

225

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1891

14316

0.96

0.94

1.8

1.7

1.6

4.99

1579

12276

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

350

0.75

0.93

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

689

0.83

0.92

1.4

1.5

2.8

4.1

0.56

149

(3046861) Legionella sp Ag [Presence] in Urine

1.55

0.91

1.2

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

148

939

1.15

0.91

1.0

1.1

300.5

283.0

mg/l

1.83

134

835

(40761536) Microorganisms panel - Urine sediment

1636

11473

1.04

0.90

5.0

4.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.50

0.90

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.50

0.90

1.1

10.1

12.8

u/l

0.24

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

356

0.76

0.90

1.8

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

158

1.39

0.90

1.8

1.6

—

(3011288) Drugs identified in Urine by Screen method

133

1120

0.87

0.90

4.7

3.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

202

1.34

0.90

1.3

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

562

1.19

0.89

1.2

1.5

13.6

8.4

ug/l

0.61

514

(3020618) Glucose [Moles/volume] in Synovial fluid

1.72

0.88

1.1

1.0

7.7

4.9

mmol/l

—

(4133840)

370

0.77

0.87

1.2

—

(3008295) Osmolality of Serum or Plasma

227

1486

1.12

0.87

1.4

1.3

276.3

277.1

mosm/kgh2o

0.17

172

1129

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

185

0.67

0.86

1.2

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

1.74

0.85

1.0

1.3

9.4

16.5

mmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.99

0.85

6.2

3.9

—

(4027681)

571

0.82

0.85

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

102

0.57

0.85

1.1

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

269

0.73

0.84

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

562

0.82

0.84

1.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.90

0.82

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

300

0.75

0.81

1.0

1.1

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.80

0.0

1.1

—

0.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.71

0.80

1.0

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

659

4536

1.06

0.79

1.1

21.3

11.7

u/ml

0.18

(4024509)

182

1480

0.90

0.75

1.7

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

179

0.69

0.75

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

127

0.63

0.75

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

153

0.67

0.74

1.6

2.0

13.9

18.3

umol/l

1.29

153

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

440

1.19

0.74

1.1

95.1

99.5

0.50

353

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.64

0.73

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.54

0.73

1.0

1.2

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

140

1.36

0.72

1.3

1.4

—

416.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

310

0.78

0.72

1.1

1.2

1.6

3.0

umol/l

6.02

283

(3036670) Protein [Mass/volume] in Synovial fluid

509

1.18

0.71

1.1

1.3

39.8

40.5

g/l

0.19

269

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

285

0.77

0.71

2.7

4.8

37.3

55.7

u/l

0.94

(36660697) Celiac disease serology panel - Serum

1268

8904

1.04

0.71

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

125

0.64

0.71

1.2

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

666

1.15

0.70

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

243

0.75

0.70

1.4

1.5

3.2

2.4

ug/l

0.44

137

(3036071) Salmonella sp Ab [Titer] in Serum

341

0.79

0.69

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

815

0.87

0.69

1.6

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

115

0.63

0.68

1.2

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

520

1.16

0.66

2.6

2.9

31.2

28.9

umol/l

0.81

399

(3010370) Gastrin [Moles/volume] in Serum or Plasma

207

1.27

0.66

1.8

1.6

78.2

47.4

pmol/l

0.57

170

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.61

0.65

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

14794

108607

0.98

0.64

30.3

18.4

14.1

13.8

135.16

14520

106098

(3000285) Sodium [Moles/volume] in Blood

195

1.27

0.64

1.2

—

(40762814) Titanium [Mass/volume] in Blood

336

0.80

0.63

2.0

2.3

3.3

3.7

ug/l

0.42

121

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

152

1229

0.90

0.61

1.0

2.6

2.8

u/ml

0.06

574

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

229

0.76

0.61

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

171

0.73

0.61

1.1

2.0

1.5

11.2

ug/l

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

414

0.83

0.61

1.1

1.3

142.1

130.4

nmol/l

0.22

291

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

125

813

1.12

0.60

1.3

2.0

—

(40768441) Liver Pathology biopsy report

130

1059

0.89

0.60

1.2

1.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.54

0.59

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.54

0.59

1.3

461.8

647.7

nmol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

147

1188

0.90

0.59

1.1

1.0

1.5

1.0

u/ml

0.28

480

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.75

0.58

1.2

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

125

815

1.12

0.58

1.3

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

125

815

1.12

0.58

1.3

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

125

815

1.12

0.58

1.3

2.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.50

0.57

1.0

2.6

1.4

u/field

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.68

0.57

1.2

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

458

0.84

0.57

1.9

3.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

315

0.81

0.57

2.1

1.8

7.3

9.0

mg/l

1.17

249

(37021550) Renin [Units/volume] in Plasma --upright

323

0.81

0.57

1.3

1.2

122.9

58.3

mu/l

0.95

236

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

399

1.17

0.57

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.37

0.55

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

241

0.79

0.55

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

167

0.74

0.54

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

135

1.30

0.54

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

239

1878

0.93

0.54

3.3

3.5

7.9

9.5

nmol/l

0.20

233

1836

(3013139) Helicobacter pylori Ag [Presence] in Stool

1089

8214

0.97

0.53

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

207

0.78

0.52

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

231

0.79

0.52

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

403

1.16

0.51

1.3

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

382

0.84

0.51

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

0.77

0.51

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

101

824

0.89

0.51

2.2

2.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

389

0.84

0.50

1.1

1.3

26.7

22.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.34

0.50

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

330

1.17

0.49

1.1

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.64

0.49

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

107

701

1.11

0.49

1.4

1.3

1.5

g/l

0.15

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

297

1.18

0.48

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

358

1.16

0.48

2.1

2.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

118

1.30

0.48

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

278

1902

1.07

0.48

1.7

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

106

696

1.11

0.47

1.8

1.9

81.7

806.7

u/l

2.26

207

(3028717) Thiamine [Mass/volume] in Blood

138

0.74

0.47

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.33

0.46

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

176

1389

0.92

0.46

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

265

1.18

0.46

1.2

—

(3000494) Fungus identified in Specimen by Culture

2238

16659

0.98

0.45

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

101

817

0.90

0.45

2.2

2.8

36.3

0.00

256

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.42

0.45

1.3

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.42

0.45

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

186

1.22

0.44

2.3

2.1

—

(44806071)

152

0.77

0.43

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.42

0.0

1.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

598

1.11

0.42

1.2

1.1

ratio

0.85

202

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18563

135005

1.02

0.42

25.2

14.9

26.9

26.7

mg/l

0.32

16375

107942

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

582

0.89

0.42

1.1

1.2

57.6

62.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

209

1426

1.07

0.41

1.2

8.0

7.7

mmol/l

0.79

144

1006

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

17468

127868

0.99

0.41

5.5

4.0

1.4

1.3

mmol/l

23.48

16253

113784

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.52

0.41

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

357

1.14

0.41

1.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.41

0.0

1.6

—

14.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

136.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2740

20323

0.98

0.41

1.3

52.3

42.2

iu/ml

1.27

829

6236

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.36

0.41

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4786

34504

1.01

0.40

4.3

3.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.68

0.40

1.3

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.43

0.40

1.6

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.67

0.40

8.0

6.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.46

0.40

1.4

1.8

2.3

mmol/24h

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.66

0.40

4.0

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

0.80

0.39

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

162

1.22

0.39

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

209

1.19

0.39

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

189

1.20

0.39

2.3

2.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

539

1.11

0.38

1.2

6.0

6.2

mmol/l

0.86

514

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

203

1.19

0.38

1.9

2.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

189

0.81

0.38

1.4

1.2

—

77.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

108

0.74

0.37

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

110

1.26

0.37

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

513

3603

1.04

0.37

1.6

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

597

1.10

0.36

1.0

1.1

10.1

10.7

iu/ml

0.08

132

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

277

2128

0.95

0.36

2.3

2.6

481.3

1392.1

u/ml

0.89

272

2099

(3010503) CD19 cells [#/volume] in Blood

114

903

0.92

0.36

1.9

2.6

0.1

0.4

e9/l

2.58

108

873

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

124

1.24

0.36

1.4

1.3

0.9

1.0

ml/s/173m2

0.16

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

0.77

0.35

1.2

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

250

0.85

0.35

1.7

1.5

30.0

62.5

au/ml

—

(46235168) Fasting glucose [Moles/volume] in Blood

171

0.81

0.35

1.8

2.6

8.3

7.2

mmol/l

1.22

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

280

1.15

0.35

1.6

3.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

418

1.12

0.35

1.0

1.1

1672.5

1499.9

miu/ml

0.55

418

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

183

1254

1.07

0.35

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

214

1474

1.06

0.34

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

301

1.14

0.34

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

124

839

1.08

0.33

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

460

3483

0.96

0.33

1.2

1.3

—

(3048879) Bone marrow aspiration report

557

0.90

0.33

1.3

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

130

0.79

0.33

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

130

0.79

0.33

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

785

0.92

0.33

1.2

1.3

37.7

29.4

u/l

1.43

620

(3017509) Phencyclidine [Presence] in Urine

0.67

0.33

1.3

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

247

1711

1.05

0.33

3.0

3.5

63.9

58.2

3.36

151

1100

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

132

1.22

0.33

1.2

11.3

10.1

mmol/l

0.55

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

124

840

1.08

0.33

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

227

1.16

0.33

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

258

1977

0.95

0.32

4.2

4.7

345.7

351.9

umol/l

0.29

217

1651

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

124

841

1.08

0.32

1.2

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

148

1011

1.07

0.32

3.4

3.8

112.4

148.9

nmol/l

1.16

148

996

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.72

0.31

1.6

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

184

0.83

0.31

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

270

1.14

0.30

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

567

4010

1.03

0.30

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

124

844

1.07

0.30

1.2

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.26

0.30

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

124

845

1.07

0.29

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

124

845

1.07

0.29

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3347

24139

1.01

0.29

1.3

1.2

1.8

2.0

u/ml

0.50

780

5896

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

354

1.11

0.29

1.2

243.2

278.7

pmol/l

0.37

257

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.72

0.29

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

175

1.17

0.29

1.6

2.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

755

0.93

0.28

1.0

1.1

6.5

6.6

nmol/l

0.01

162

(3004616) Nuclear Ab [Presence] in Serum

213

1632

0.95

0.28

1.2

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2563

18940

0.99

0.28

1.3

1.2

16.9

15.0

u/ml

0.45

855

6618

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

166

0.83

0.28

1.2

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

633

0.92

0.28

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.76

0.28

1.2

1.3

253.1

373.5

umol/24h

—

(3021788) Differential panel - Synovial fluid

406

2863

1.04

0.27

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

571

0.92

0.27

1.7

2.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

212

1476

1.05

0.26

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

141

0.83

0.26

1.1

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13317

97495

0.99

0.26

4.0

3.8

15.1

15.0

pmol/l

1.68

12016

86554

(3016244) Insulin [Units/volume] in Serum or Plasma

486

0.92

0.25

2.6

3.3

23.8

24.3

mu/l

0.04

453

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

109

848

0.94

0.25

1.8

2.6

0.2

e9/l

1.56

750

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.30

0.25

1.0

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

218

0.87

0.25

1.0

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

388

2741

1.03

0.24

1.5

1.7

29.2

4.7

iu/l

0.47

121

853

(3029396) Erythrocyte agglutination [Presence] in Blood

1.17

0.24

1.7

1.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.72

0.24

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.72

0.24

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

416

0.91

0.24

1.5

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

117

1.18

0.24

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.20

0.23

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.26

0.22

1.0

3.0

2.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

442

3315

0.97

0.22

1.8

1.7

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.22

0.0

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.22

0.0

2.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

135.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.21

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.78

0.21

1.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.18

0.21

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

629

4690

0.98

0.21

1.1

300.5

195.9

titre

0.35

128

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.82

0.20

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.81

0.20

6.6

4.9

—

(4212803)

160

0.87

0.20

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

130

903

1.05

0.20

1.8

2.1

—

(3011412) CD3 cells [#/volume] in Blood

171

1300

0.96

0.19

1.8

2.4

1.0

1.1

e9/l

0.62

101

763

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

113

0.84

0.19

1.2

1.1

0.0

0.9

u/ml

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

159

0.87

0.19

1.2

2.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

492

0.93

0.18

1.2

1.1

—

(44813793)

103

713

1.05

0.18

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

246

1.10

0.18

2.8

2.4

86.3

118.1

au/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

393

2797

1.03

0.18

1.1

16.9

9.0

u/ml

0.37

258

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

166

0.88

0.18

1.2

3.1

39.6

168.6

ng/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.13

0.17

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

128

1.14

0.17

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.72

0.17

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.17

0.16

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

410

1.07

0.16

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

460

1.06

0.16

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1860

13438

1.01

0.16

2.2

192.7

160.4

ug/g

2.12

1484

10437

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

241

1.09

0.16

1.1

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.10

0.16

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

418

1.06

0.16

1.7

2.0

30.4

30.2

0.02

386

(40758358) Immune stain study

0.74

0.15

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

412

1.06

0.15

1.7

2.0

11.6

11.1

0.08

371

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.80

0.15

1.0

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

278

1.08

0.14

1.7

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

117

0.87

0.14

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

203

1439

1.03

0.14

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

128

968

0.96

0.13

1.7

2.0

14.0

15.3

0.40

374

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.18

0.13

1.0

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

272

1.07

0.13

3.5

3.1

6.6

7.6

mg/l

0.53

219

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.83

0.13

1.0

1.1

—

3.3

u/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.82

0.13

2.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

658

1.04

0.13

1.4

2.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

169

0.91

0.12

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

184

0.91

0.12

1.6

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

659

1.04

0.12

1.4

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

152

1077

1.03

0.11

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

112

790

1.03

0.11

1.5

1.3

1.6

1.3

u/ml

0.17

428

(3038026) Centromere Ab [Units/volume] in Serum

151

1132

0.97

0.11

1.2

54.8

47.7

u/ml

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

168

1.09

0.11

19.8

9.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

211

1.07

0.10

1.4

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

212

0.93

0.10

1.1

1.2

49.0

54.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.11

0.10

2.0

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.88

0.09

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.88

0.09

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.04

0.09

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

226

0.94

0.09

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

243

1740

1.02

0.09

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

0.83

0.08

2.4

1.6

—

(3013762) Body weight Measured

0.81

0.08

1.0

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.11

0.08

2.8

3.0

25.7

63.5

pmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

263

1.05

0.08

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.11

0.08

1.3

1.1

—

(4015189)

472

1.04

0.08

2.5

2.2

—

(3042517) Benzodiazepines panel - Urine

1.08

0.07

1.8

2.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.08

0.07

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

167

1242

0.98

0.07

1.7

1.9

5.1

3.9

mg/l

2.49

155

1188

(3009015) Lactate [Moles/volume] in Synovial fluid

171

1.07

0.07

1.1

1.3

5.4

7.0

mmol/l

1.06

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

148

1102

0.98

0.07

1.2

92.3

88.4

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

668

1.03

0.07

1.4

2.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

150

1.07

0.07

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

150

1.07

0.07

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

150

1.07

0.07

1.0

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.03

0.07

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.88

0.06

1.7

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

473

0.97

0.05

1.7

1.4

1647046.7

1612637.2

iu/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

149

1105

0.98

0.05

1.2

38.7

39.9

u/ml

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.09

0.05

1.2

1.4

43.1

40.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

133

987

0.98

0.05

1.8

2.0

72.5

70.7

0.74

123

940

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

155

0.94

0.05

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

120

891

0.98

0.05

1.8

2.6

464.3

535.3

e6/l

0.85

758

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

146

1049

1.02

0.05

1.2

24.8

3.0

u/ml

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

110

0.93

0.05

1.1

1.0

96.2

83.4

ug/l

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

109

1.07

0.04

1.1

1.0

—

4.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

688

1.02

0.04

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

232

1676

1.01

0.04

1.2

144.4

211.3

miu/ml

1.07

565

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

392

2879

0.99

0.04

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

381

2762

1.01

0.03

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

530

1.02

0.03

1.2

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.93

0.03

2.3

2.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

13873

101153

1.00

0.03

4.7

4.1

16.1

13.1

mm/h

71.01

12804

92366

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

264

1913

1.01

0.02

1.4

1.5

67.8

60.3

2.55

172

1220

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

191

1382

1.01

0.02

1.1

2.6

2.1

iu/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

475

0.98

0.02

1.8

2.0

—

(3045142) Bone marrow Pathology biopsy report

254

1843

1.01

0.02

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

329

1.02

0.02

1.2

2.3

—

(3051101) Glucose [Moles/volume] in Cord blood

308

1.02

0.01

6.0

6.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

101

743

0.99

0.01

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

102

750

0.99

0.01

1.2

—

(4198724)

287

1.02

0.00

1.4

2.1

—

(3028433) Virus identified in Specimen by Culture

508

0.99

0.00

1.1

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.06

0.00

2.3

1.3

1.0

1.1

u/field

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.03

0.00

1.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

113

1.03

0.00

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

175

1.00

0.00

1.1

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

194

1413

1.00

0.00

1.4

1.5

20.7

30.0

3.67

122

875

(3005011) Chlamydia sp Ab [Titer] in Serum

147

0.99

0.00

1.8

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

195

1.01

0.00

1.3

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

197

1.00

0.00

1.1

1.0

0.8

1.0

u/ml

0.10

(3000060) B lymphocytes [#/volume] in Blood

281

0.99

0.00

1.7

2.0

657.0

1823.7

e6/l

0.54

142

(3011897) Casein IgE Ab [Units/volume] in Serum

1.01

0.00

1.1

0.3

0.6

u/ml

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.01

0.00

1.0

1.3

1.0

0.7

u/field

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.98

0.00

1.7

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.89

0.00

1.0

1.1

0.1

mg/l

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.99

0.00

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.96

0.00

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.87

0.00

1.4

1.3

—

(3013466) aPTT in Blood by Coagulation assay

0.89

0.00

1.0

1.1

38.6

38.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_MI_STRICT and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_MI_STRICT	1.911 [1.75, 2.08]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.059

During the follow-up period (1.1.1998 — 31.12.2019), 36413 out of 66544 females with I9_MI_STRICT died.

Males

Parameter	HR [95% CI]	p-value
I9_MI_STRICT	1.74 [1.59, 1.9]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 40448 out of 99273 males with I9_MI_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have I9_MI_STRICT.

N-year risk	Females	Males
1	0.154%	0.204%
5	0.961%	1.551%
10	2.548%	3.994%
15	4.673%	7.468%
20	7.911%	12.775%

Relationships between endpoints

↥

Index endpoint: I9_MI_STRICT – Myocardial infarction, strict

GWS hits: 81

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Myocardial infarction, strict

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints